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The Bcl-2 family is commonly associated with cell death, but a new function in 
differentiation has been demonstrated. Diva (death inducer binding to vBcl-2 and Apaf-1) 
is a Bcl-2 family member, and has been reported to play roles in apoptosis and oocyte 
maturation.  More interestingly, Diva has a high expression in embryonic tissues, but its 
expression in adult tissues is restricted to reproductive tissues. Diva has also been shown 
to interact with Nm23-H2/NDPK B, which is involved in cellular differentiation. 
Collectively, these findings suggest a possible role for Diva in differentiation, for which 
there has been no previous report. Hence, this study aimed to elucidate the function and 
possible mechanisms for Diva in differentiation.  
In the present study, in PC-12 cells, Diva expression was decreased after 
differentiation and reciprocally, NDPK B expression was increased and it translocated 
into the nucleus. Endogenous Diva was also shown to interact with both β-tubulin and 
NDPK B. 
Overexpression of Diva in PC-12 cells did not change the expression level of 
NDPK B, but inhibited its nuclear localization. Diva-overexpressing cells had a 
decreased percentage of differentiated cells (from 64.86±3.39% to 53.76±3.75%) and 
average neurite length was shortened from 28.74 ± 1.55 µm to 25.6 ± 0.66µm. This was 
due to the formation of more Diva/NDPK B and Diva/β-tubulin complexes, at the 
expense of NDPK B/β-tubulin complexes. Diva overexpressing cells also had a 
significantly elevated proliferation rate, with increased expression of cyclin D1, pRB and 
E2F-1 and concomitant decrease of p27 and p15 levels. 
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Overexpression of NDPK B in PC-12 cells resulted in decreased Diva expression 
and increased β-tubulin expression. In addition, there was an increase in percentage of 
differentiated cells (from 64.86±3.39% to 82.4±2.81%) and average neurite length (from 
28.74 ± 1.55 to 45.42.6 ± 1.54µm) due to more NDPK B/β-tubulin complexes being 
formed. NDPK B overexpression also inhibited cellular proliferation, by decreasing 
cyclin D1 and D3 levels as well as increasing p27 and p15 levels.  
In contrast, transfection of Diva and NDPK B plasmids individually into primary 
MSCs resulted in the appearance of a small percentage of oligodendrocyte-like cells, and 
there was a large amount of Diva/NDPK B complexes only in these cells. 
Hence, the present results suggest a novel role for Diva in the negative regulation 
of neuronal differentiation. Its downregulation during neuronal differentiation is 
necessary to allow increased amounts of NDPK B/β-tubulin complexes that promote 
neurite outgrowth. Decreased Diva expression is also required for translocation of NDPK 
B into the nucleus to inhibit cell proliferation during differentiation. An elevated level of 
NDPK B in the nucleus leads to increased expressions of cyclins, pRB and E2F-1 as well 
as decreased expressions of p27 and p15. Overexpression of Diva and NDPK B in MSCs 
resulted in oligodendrogenesis, which suggest a possible role for Diva in cell fate 
determination as well. 
The findings obtained in this study have exciting applications in the area of stem 
cell research, which can be used in the treatment of numerous CNS diseases. Current 
protocols have low differentiation rates for stem cells, and manipulation of Diva and 
NDPK B expressions may be able to help enrich neuronal or oligodendrocytic 
iii 
 
subpopulations. NDPK B overexpression may also decrease the chance of teratoma 
formation during transplantation. 
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The focus of the thesis is to examine the role of Diva, a Bcl-2 family member, in the 
role of differentiation in the central nervous system. Diva has been found to associate 
with NDPK B, which has roles in differentiation and cell cycle regulation. Hence, the 
project sought to elucidate how the expression and interaction of these 2 proteins 
might regulate differentiation and cell cycle regulation. 
1.1 Apoptosis and Differentiation in the development of the Central Nervous 
System 
The brain develops from the early embryonic ectoderm and continues to develop 
postnatally. After gastrulation, the mesoderm gives rise to the notochord in an 
anteroposterior axis. The overlying ectoderm will then receive signals to form the neural 
plate, which folds and forms the neural tube which eventually develops into the different 
structures of the brain (Madden and Cotter, 2008). The complex process of development 
involves neural induction, migration, differentiation and apoptosis. In brief, the process is 
as such: The first step is the identification of the neural plate, during neural induction 
when competent ectodermal cells are gifted with the ability to become precursors. Next, 
there is specific initiation of neural differentiation in a selected number of sites within the 
neural plate.  Neural differentiation is the acquisition of neural cell identity by a 
progenitor cell, characterized with a change in cellular morphology (eg neurite 
outgrowth), gain in function (eg ability to generate action potentials) and exit of the cell 






After neurons are produced in the cortical progenitor department, the later born 
neurons would migrate and settle in more superficial layers, resulting in an inside-first 
and outside-last neurogenic gradient. However, there is a surplus of neurons at birth, and 
programmed cell death, otherwise known as apoptosis, eliminates the excess neurons to 
adjust the number of innervation neurons to the size of their target population 
(Oppenheim 1991). In the mammalian brain, this pruning process takes place during the 
period of the growth spurt, which in human starts in the 3
rd
  trimester of gestation and 
ends by the third year of life (Ikonomidou 2009). Apoptosis is characterized by shrinkage 
and condensation of the cell body, fragmentation of the nucleus and exit from the cell 
cycle. 
Therefore in recent years, there has been interest in examining how cell cycle exit is 
involved in development, from neural differentiation to death. 
1.2 Cell cycle 
The cell cycle starts with a release of cells from a quiescent state (G0), before they enter 
the first gap phase (G1) to prepare for DNA replication in the synthetic phase (S). After 
the second gap phase (G2) and mitosis phase (M), the cell would have completed one 
cycle and continues into the next if there are proliferative signals, or exits the cell cycle 
and enters the G0 resting phase. Progression through these phases is tightly controlled by 
checkpoints, which ensure that critical events in one phase are completed before the next 
phase is initiated. Cells arrested at any of the checkpoints have several route options. 







1.2.1 Cyclins and Cyclin Dependent Kinases (CDK) 
CDKs are serine/threonine kinases that form heterodimeric complexes after binding 
to their regulatory subunits. Positive regulation of CDK activity is by association with the 
cyclin and by phosphorylation of the T-loop threonine by CDK-activating kinase (Park 
and Lee, 2003). The levels of activating cyclins changes throughout the different stages 
of the cell cycle, but CDK levels remain constant (Vermeulen et al., 2003). The cyclins 
can be categorized into 2 groups- mitotic cyclins like cyclins A and B; or G1 cyclins like 
cyclin C, D and E. The regulation of G1/S transition has received much attention because 
passage through this point commits the cell to complete the cycle and divide. The G1/S 
checkpoint is controlled by the active complexes of D-type cyclins (cyclin D1, D2 and 
D3) with Cdk4 and Cdk 6, which govern the early G1 phase, and active complexes of 
CDK2 with cyclins E1 and E2 which control the late G1 phase. The S/G transition is 
controlled by cyclin A/CDK2 complex, and mitosis is initiated when cyclin B/CDK1 
complex (otherwise known as mitosis promoting factor) is translocated from the 
cytoplasm into the nucleus. Finally, the destruction of cyclin B results in exit from 










Figure 1 The cell cycle and its main regulators. The D-type cyclins (D1, D2 and D3) 
are induced when G0 quiescent cells are induced to enter the cell cycle. They bind to the 
cyclin dependent kinases (CDK) 4 and 6. The active cyclinD/CDK4/6 phosphorylate the 
Rb protein that releases the activated transcription factor E2F to transcribe genes required 
for S phase entry. Cyclin E activates CDK 2 so that G1 can progress to S phase. During 
the S phase, cyclin A binds to CDK 1 and CDK 2. B type cyclins associate with CDK 1 
for G2 exit and mitosis phase. The INK4 family CDK inhibitors (CDKIs), p15, p16, p18 
and p19 regulate the cyclinD/CDK4/6. The Cip/Kip family, which includes p21 and p21, 
regulate the Cyclin A/Cylin E/CDK2 complexes. These CDKIs are transcriptionally 
induced by p53. G0: quiescent state; G1: first gap phase; S: DNA replication phase; G2: 
second gap phase; M: mitosis. Figure is adapted from Becker and Bonni (2004). Progress 
in Neurobiology 72, 1-25. 
 
When quiescent cells enter the cell cycle due to mitogenic signals, D-type cyclins 
(D1, D2 and D3) are induced and they assemble with CDK 4 and 6. In addition, there is 
increased gene transcription and cyclin D-CDK complex assembly due to mitogen-
induced Ras signaling. These cyclin D-CDK complexes then enter the cell nucleus and 






starvation, cyclin D1 is phosphorylated at Thr-286 reside by glycogen synthase-3β (Diehl 
et al. 1998). This enhances its nuclear export and accelerates its ubiquitin-dependent 
proteasomal degradation. Hence, cyclin D transcription, assembly, nuclear transport and 
turnover provides the link between mitogenic signals and cell cycle regulation. In that 
way, constitutive activation of the D cyclin pathway can reduce or overcome mitogen 
requirements for cell proliferation, thereby contributing to cancer. 
1.2.2 Cyclin Dependent Kinases Inhibitors (CDKIs) 
Another function of cyclinD-CDK 4 complexes is sequestration of CDKIs. CDK 
inhibitors and subdivided into two families based on their structures and CDK targets. 
The INK4 proteins (inhibitors of CKD4) comprises of p16INK4a, p15INK4b, p18INK4c 
and p19INK4d. They specifically inhibit the catalytic subunits of CDK 4 and 6, by 
inducing allosteric changes that affect the binding of D-type cyclins. In contrast, the 
Cip/Kip family has a wider range, inhibiting cyclin D-, E- and A- dependent kinases. 
Members of this class include p21Cip1, p27Kip1 and p57Kip2. CDK inhibitors 
accumulate quickly and inhibit CDK activity when presented with differentiation or 
quiescent promoting signals (as reviewed in Galderisi et al., 2003). 
The INK4 proteins are negative regulators of the G1-phase. P16INK4a has been 
shown to accumulate as cells approach senescence (Serrano et al., 1997) whereas 
p18INK4c and p19INK4d are expressed in the course of fetal development and are 
suggested to have roles in terminal differentiation (Phelps et al., 1998). The cell is 
arrested in G1 phase when INK4 proteins are expressed (Guan et al., 1994; Medema et 






binary complex with an INK4 protein. Therefore, increased INK4 amounts would shift 
the distribution of CDK4 towards INK4-CDK complexes and reverse the normal 
sequestration of Cip/Kip proteins. The free Cip/Kip proteins then inhibit cyclin E-CDK2 
and lead to G1-phase arrest.  
Levels of p27Kip1 are high in quiescent cells, whereas p21Cip1 starts off with 
relatively low levels that increase with G1 phase progression. When there is a mitogenic 
signal, increased amounts of cyclin D-complexes would assemble with the Cip/Kip 
proteins, which relieves cyclin E-CDK2 from its constraints to facilitate its own 
activation by triggering p27Kip1 degradation. Conversely, when there is withdrawal of 
mitogenic signals, latent pools of Cip/Kip proteins are no longer sequestered by cyclin D-
complexes and they inhibit cyclin E-complexes to cause G1-arrest (Sherr et al., 1999). 
Although it seems counterintuitive because of their nomenclature, the Cip/Kip family 
of proteins increases the stability of cyclin D-CDK complexes, and directs their 
accumulation in the nucleus (Cheng et al., 1999 and LaBaer et al., 1997). Therefore, 
Cip/Kip proteins act as positive regulators of cyclinD-CDK complexes. The two 
functions of cyclinD-CDK complexes-Rb phosphorylation and CDKI sequestration- are 
compatible because the Cip/Kip proteins do not inhibit the Rb kinase activity of the 
cyclinD-CDK complexes.  
1.2.3 CDK substrates 
The well-established function of cyclin-D dependent kinases is phosphorylation of 
members of the retinoblastoma protein (Rb), including p107 and p130 in mid-G1 phase. 






Rb members and Rb is maintained in a hyperphosphorylated state throughout the cell 
cycle by cyclin A- and cyclin B-dependent kinases until cells exit mitosis. 
Hyperphosphorylation of Rb causes its dissociation from E2F family members, which are 
transcription complexes composing of an E2F subunit (E2F1-6) and a DP partner (DP1 
and 2). As a result, E2F binds to the promotors of S-phase regulators and there is 
transcription of genes necessary for DNA synthesis and S-phase progression, such as 
cyclin E. Rb phosphorylation is then enforced by the cyclinE-CDK2 complex, creating a 
positive feedback loop that contributes to the irreversibility of the G1/S transition. 
Unsurprisingly, overexpression of E2F is sufficient to drive quiescent cells into S-phase 
(Qin et al, 1994), which indicates its central role in regulating the G1 to S phase 
transition. 
Rb is returned to a hypophosphorylated state in the next G1-phase. The Rb protein is 
active when underphosphorylated, and inhibits G1/S progression by inhibiting E2F 
transcription factors. Cyclin D-dependent kinases are specific in phosphorylating only 
Rb, and not histone H1, which is the canonical CDK substrate (Kato et al., 1993). On the 
other hand, cyclin E-CDK2 phosphorylated both Rb, histone H1 and even p27Kip1 (Koff 
et al., 1992; Vlach et al., 1997). 
1.2.4 Modulators of cell cycle machinery 
The cell cycle regulatory proteins have to be tightly coordinated to ensure the timely 
progression from one phase to the next. As mentioned, cyclin/CDK complexes can be 
modulated by CDKIs. The cyclin/CDK complexes can also be regulated by CAK, or 






G2/M (Edgar et al., 1994). Cyclin expression levels are governed by proteolytic 
degradation, as well as transcriptional, translational and post-translational mechanisms 
(Amon et al., 1994). 
1.3  Histogenesis and cell cycle 
The development of the brain, including size regulation in the brain, histogenesis, 
neurogenesis and maintenance of stem cell pools, requires both proliferation and 
differentiation. In cell cycle terms, this would mean the entrance and exit of the cell 
cycle. Therefore, it is impertinent to examine the processes of cell cycle regulation and 
cell specification.  
The size of the brain is determined by the number of times neuroblasts enter the cell 
cycle, which is in turn governed by cell cycle machinery. This was demonstrated by the 
fact that p27kip1 deficient mice had enlarged brains (Nakayama et al., 1996). The switch 
from symmetrical divisions, which results in 2 cycling daughter cells, to asymmetrical 
divisions which has only 1 resultant cycling daughter cell, also explains how the cell 
cycle regulates brain size. Expression of constitutively active β-catenin, increased the 
number of precursors re-entering the cell cycle during cortical neurogenesis therefore 
resulting in an enlarged brain size (Chenn and Walsh, 2002). Lastly, brain size is also 
determined by the average cell size. Neurons can become enlarged when there is 
endoreplication without cytokinesis, as seen when there is cyclin E ablation in mouse 
(Geng et al., 2003). In fact, the control of cell cycle regulators on brain size is likely to be 






cerebellum (Fantl et al., 1995; Huard et al., 1999), and cyclin D2 in distinct rhombomeres 
in the hindbrain (Wianny et al., 1998). 
Histogenesis is the process where the cell exits the cell cycle and progresses along a 
pre-determined fate. A clear example of histogenesis is the generation of neurons prior to 
glial cells. The expression of p27kip1 increases in glial progenitors until a sufficiently 
high level before it causes oligodendrocyte precursors to exit the cell cycle and 
differentiate (Durand and Raff , 2000). Interestingly, when increase in expression of 
p27kip1 is accelerated, the rate of differentiation is higher, indicating that 
oligodendrocyte precursors could be measuring proliferative time using CDK inhibitor 
levels (Gao et al., 1997). P27Xic1 is also involved with cell cycle exit coupled with 
differentiation of Mϋller glial cells, and analysis of its functional domain reveal that it is 
bifunctional, with overlapping yet separable domains for cyclin kinase inhibition and 
Mϋller glial determination (Ohnuma et al., 1999). There is a large wealth of information 
detailing how transcriptional factors, such as basic helix-loop-helix (bHLH) proneural 
genes, have a major role in fate determination. Xath 5, a bHLH transcriptional factor, 
induces the early exit and differentiation into retinal ganglion cells. When co-transfected 
with p27Xic1 (which induces differentiation into Mϋller glial cells), the cells were almost 
all retinal ganglion cells, indicating the determinative power of proneural genes to be 
more significant than CDKI (Ohnuma et al., 2002). The authors also suggest an entangled 
network of cell cycle components affecting molecular machinery that determines cell 
fate, and vice versa. They argue that the Notch pathway regulates neurogenesis early by 
helping bHLH expressing cells to exit the cell cycle but regulates gliogenesis later by 






Neural differentiation events are linked to specific cell cycle phases, and are 
determined around the final cell cycle. This is illustrated in the transplantation of young 
progenitor cells into older animals. The precursor cells would change their fate according 
to the environment only if they are transplanted in G1/S phases, and would retain their 
original fates if transplanted at M phase (MacConnell and Kaznowski, 1991). In addition, 
determination can be regulated by inheritance of the determinants during M-phase. 
Numb, a well-known antagonist of the Notch pathway is asymmetrically inherited during 
division. In humans, alternative splicing of Numb generates 2 transcripts that determine 
cell fate choice and another 2 transcripts that activate proliferation (Verdi et al., 1999). 
The G1/S checkpoint is located at the end of the G1 phase. Once this restriction point is 
cleared, the cell will be obligated to complete the cell cycle. Therefore, in order to 
differentiate, it is necessary for the cell to leave the cell cycle in G1 and enter G0 while 
bypassing the G1/S restriction point. It would be logical to deduce that blockage of the 
cell cycle in G1 would invariably promote differentiation, and driving cells through G1 
would then inhibit differentiation. Ohnuma et al (2002) demonstrated that through 
overexpression of p27Xic1, cells were blocked in G1 and activity of proneural genes was 
potentiated. Overexpression of cyclin E gave the opposite result. As a matter of fact, most 
components of G1 cell cycle regulation have been shown to affect neural determination.  
Cyclin D1 and D3 were reported to respectively regulate transcriptional activity of bHLH 
gene NeuroD (Ratineau et al., 2002) and retinoic acid receptor α, which promotes 
neurogenesis (Despouy et al., 2003). However, the influence of these cell cycle arrest 
factors on determination pathways is not unidirectional. Many determination factors are 






proneural genes NeuroD2, Mash1 or neurogenin-1 induced the expression of p27kip1 and 
caused cell cycle arrest in G1 while converting P19 embryonic cells into differentiated 
neurons (Farah et al., 2000). G1 cell cycle components are also involved when external 
neural determination and proliferation signals induce the differentiation status of the cell. 
Wnt modulates cyclin D1, D2 and c-myc expressions, while Shh moderates cyclin D1 
and N-myc expressions (Baek et al., 2003 and Kenney et al., 2003). 
Stem cells are an interesting case in cell cycle studies. They divide very slowly in a 
symmetrical manner, and this slow cycling has been attributed to the low expression of 
cell cycle activators since Ohnuma et al (2002) showed that expression of cyclin A2, E2 
and D1 was lower in the stem cell population as compared to proliferating early 
retinoblasts. An even more intriguing idea is that mature Mϋller glial cells can re-enter 
the cell cycle during injury and transdifferentiate into neurons. These cells do not divide 
under normal circumstances as they have high levels of p27kip1, which would be 
downregulated upon reactivation, therefore allowing the cells to move onto S phase (Reh 
and Levine, 1998). This story was affirmed by mice lacking p27kip1, who displayed a 
constitutive state of gliosis (Dyer and Cepko, 2000). 
Although some molecular interactions and pathways have been clarified, some 
questions still remain unanswered. What are the molecular mechanisms coordinating cell 
cycling and differentiation? How do the components of these 2 systems synchronize to 
achieve accurate timing for the different neural cell types? In recent years, dual function 
molecules that couple cell fate and cell cycle have been described and therefore shed 
some light into these questions. Homeodomain proteins, such as Prospero in Drosophilia, 






differentiation and cell cycle exit (Li and Vanessin 2000, Torii et al., 1999, Dubreuil et 
al., 2000). Tramtrack, a key transcriptional repressor inducing glial fate, downregulates 
cyclin E and thereby inhibits cell cycle progression (Badenhorst 2001). Hence the search 
for more of these molecules that is central to the coordination of cell cycle and 
differentiation remains. 
1.4 Apoptosis and cell cycle 
As mentioned above, apoptosis is a major force in brain histogenesis, where the 
failure of synaptic connection results in removal through deprivation of neurotrophic 
factors. In the postnatal rat cerebrum, there is a wave of cell death peaking between 
postnatal day (P)7 and P9 in many areas, including the hippocampus and somatosensory 
cortex (Glotzner et al., 1991; Lebwohl et al., 1994). The cerebellum is also not spared, 
with astrocytic apoptosis in the internal granular layer and molecular layer (Jacobson et 
al., 1997). The postnatally developing optic nerve also has oligodendrocyte apoptosis 
(Barres et al., 1992). It was recently shown that components of the cell death machinery, 
such as Apaf-1 and caspase 3, are significantly downregulated after P10 in the mouse 
brain and retina (Madden et al., 2007, Donovan and Cotter 2002). Mice with deleted 
Apaf-1, caspase 9 and caspase 3 exhibited the consequences of aberrant developmental 
apoptosis: perinatal lethality, craniofacial abnormalities and enlarged brains (Yoshida et 
al., 1998, Kuida et al., 1998).  
In addition to developmental apoptosis, programmed cell death of neurons is also a 
prominent feature of acute and chronic neurological disease such as stroke, AD and ALS 






abnormal protein aggregates and free radical production is recognized as a major 
contributor to the neuropathology of neurodegenerative diseases (Klein and Ackerman, 
2003). Therefore, it comes as no surprise that apoptosis mediators, such as Apaf-1, 
caspase 3 and caspase 9, are involved in the pathology of neurodegenerative diseases 
such as PD, AD and ALS. After fetal and postnatal development, Apaf-1 and caspase 3 
expressions are downregulated, but caspase 9 expression is sustained. Caspase 9 can be 
made active by ER stress caused by mis-aggregation of proteins in AD and ALS (Taylor 
et al., 2002, Bredesen et al., 2006). Active caspase-3 has also been detected in the 
neurofibrillary tangles of the AD brain (Rohn et al., 2001). In addition, a dominant 
negative inhibitor of Apaf-1 was demonstrated to protect against neuronal loss in the 
substantia nigra in a PD model (Mochizuki et al., 2001).  
Therefore, work has been done to elucidate the regulation of these apoptotic genes.  
Transcription factor E2F-1 has been shown to positively regulate expression of various 
caspases, as well as Apaf-1 (Furukawa et al., 2002, Nahle et al., 2002). In turn, E2F-1 is 
negatively regulated by Rb, a tumour suppressor that arrests the cell cycle in G1 phase. 
As mentioned above, E2F-1 and Rb are both integral to the cell cycle. Hence, apoptosis 
can also be a result of aberrant cell cycle entry, as demonstrated by the targeted 
disruption of Rb. It was shown that Rb deficient mice die early during embryogenesis and 
show profound defects in neurogenesis (Clarke et al., 1992). It has also been suggested 
that Rb has a role in abortive cell cycle re-entry and subsequent apoptosis (Liu and 
Greene, 2001a). Overexpression of E2F has also been demonstrated to promote apoptosis 
following excitotoxicity (Verdaguer et al., 2002). Furthermore, expression of dominant 






withdrawal (Konishi and Bonni, 2003) and exposure to Aβ (Giovanni et al., 1999), 
suggesting that endogenous E2F is integral in neuronal apoptosis. Kranenburg et al 
(1996) also demonstrated that apoptosis induced by overexpression of cyclin D is blocked 
by expression of Bcl-2, thereby supporting the theory that cell cycle proteins and 
apoptosis share an intimate relationship. Both developmental and toxicity-induced 
apoptosis can be mediated by the G1 cyclins.  Cyclin D and CDK4 are induced in 
apoptotic brain after kainic acid insult and the infusion of anti-sense oligonucleotides 
were able to suppress the induced apoptosis (Ino and Chiba, 2001). 
However, the question of how these cell cycle proteins suppress apoptosis is still 
unanswered. A likely candidate integrating cell cycle with apoptosis is p53, the tumor 
suppressor protein. P53 inhibits cell cycle progression at the G1/S checkpoint. It can also 
directly induce the expression of Bax and Apaf-1, thereby causing apoptosis (Fortin et al., 
2001, Moroni et al., 2001). Deletion of p53 has proven to be neuroprotective in 
paradigms of neuronal apoptosis including exposure to Aβ and focal ischemia (Crumrine 
et al., 1994; Zhang et al., 2002). The importance of p53 in apoptosis is not only seen in 
pathogenic cell death. Embryonic p53-deficient neurons showed enhanced survival when 
deprived of NGF, suggesting its importance in developmental apoptosis as well (Vogel 
and Parada, 1998). There could be other mechanisms that cell cycle regulators control 
apoptosis. E2F-mediated cell death is independent of p53, but dependent on Bax, caspase 








1.5 Bcl-2 family  
Bcl-2 protein was discovered in B-cell lymphomas (Tsujimoto et al., 1985), and many 
more members of this family have been discovered subsequently. The Bcl-2 family 
encompasses both pro- and anti-apoptotic members. Anti-apoptotic members have all 4 
Bcl-2 homology domains (BH) domains, whereas pro-apoptotic members either have 
BH1, BH2 and BH3 domains, or only the BH3 domain. Examples of anti-apoptotic 
members include Bcl-2, Bcl-w, Bcl-xL and Mcl-1. Bax, Bok and Bak lack the BH4 
domain, while Bad, Bid and Bim are ―BH3 only‖ proteins. Bcl-2 family members are 
known to be able to interact with itself or other members of the family to form 
homodimers or heterodimers (Antonsson and Martinou, 2000). The induction of 
apoptosis is via the death receptor-dependent pathway (extrinsic pathway) or the 
mitochondria pathway (intrinsic pathway). Ultimately, the intracellular and extracellular 
stress signals would result in activation of pro-apoptotic Bax and Bak, or inactivation of 
anti-apoptotic proteins like Bcl-2 and Bcl-xL. Bcl-2 and Bcl-xL can be blocked by BH3-
only proteins, Bad and Bim.   
1.5.1 Bcl-2 family and development 
Bcl-2 expression is high in the developing nervous system but declines significantly 
in the post-natal brain (Merry et al., 1994). Bcl-2 deficient embryos exhibited loss of 
motorneurons, sympathetic and sensory neurons, and it occurs after the normal peak of 
apoptosis in these populations, hence suggesting that Bcl-2 is actually involved in 
maintenance of their survival, rather than regulating apoptosis per se (Michaelidis et al., 






developmental apoptosis as the knockout mice did not show any developmental defects 
(Akhtar et al., 2004). In contrast, Bcl-xL is expressed at significant levels in both the 
embryonic and mature nervous systems. Bcl-xL deficient mice had massive cell death of 
immature neurons throughout the developing system, resulting in death around 
embryonic day (E) 13.5 (Motoyama et al., 1995). The increased apoptosis is attributed to 
activation of the intrinsic pathway as there is an increase in activated caspase-3 in the 
Bcl-xL deficient mice (Roth et al., 2000). Taken together, these reports support the 
integral role of Bcl-xL in the protection of immature neurons in the developing brain. 
Bax-deficient mice showed attenuated neuronal apoptosis and increased neuron numbers 
in a myriad of sites including brainstem, cerebellum and hippocampus (White et al., 
1998). An issue faced when studying a particular function of Bcl-2 family members is 
that they may have overlapping actions and thereby compensate for each other. Hence, 
scientists have generated mice that are deficient in 2 genes. Bax and Bak dual-deficient 
mice showed perinatal lethality and other developmental abnormalities, indicating the 
concerted effort between these 2 molecules in development (Lindsten et al., 2000). 
Targeted disruption of both Bax and Bcl-xL also revealed that Bcl-xL has both Bax-
dependent and Bax-independent actions on different cell types in the developing embryo 
(Shindler et al., 1997). 
1.5.2 Bcl-2 family and differentiation 
In recent years, members of the Bcl-2 family have been gaining attention for their 
role in differentiation, which can be dependent or independent of their apoptotic function. 
Concomitant loss of pro-apoptotic BH3-only Bcl-2 antagonists Bik and Bim arrested 






testicular development is interrupted (Coultas et al., 2005). Overexpression of Bcl-W in 
the testis inhibited germ cell cycle entry and/or cell cycle progression leading to disrupted 
spermatogenesis (Yan et al., 2003), whereas Bcl-w knockout mice were sterile (Meehan 
et al., 2001). Shim et al (2004) reported that Bcl-xL overexpressing embryonic stem cells 
had enhanced midbrain dopaminergic neuron differentiation. These cells, when 
transplanted into Parkinsonian rats, displayed more extensive fiber outgrowth and even 
led to a reversal of behavioural symptoms. More recently, Bcl-xL was found to enhance 
neuron generation while precluding glia generation from human neural stem cells. This 
was achieved by increasing the proliferation of neuronal progenitors and inhibiting the 
differentiation of glial precursors. In vivo experiments showed that Bcl-xL 
overexpressing hNS1(cell-line) cells generated more neurons and less glia as well (Liste 
et al., 2007). Cells that were engineered to overexpress Bcl-2 increased expression of 
neural differentiation-associated genes and decreased expression of proliferation-related 
genes (Liang et al., 2003), as well as increased neurite outgrowth (Oh et al., 1996). 
1.5.3 Bcl-2 family and cell cycle 
The Bcl2 family members can be found in the cytosol, but they can also localize to 
subcellular organelles such as the mitochondria, ER and nucleus because of their C-
terminal hydrophobic membrane. Bcl-2 has been reported to act in G0 and at the G1/S 
transition. Vairo et al (1996) showed that the protein hastened the exit to G0 and 
increased the levels of p27, leading to a more hypophosphorylated Rb. Huang et al. 
(1997) also showed evidence that the time taken to enter S phase was lengthened by Bcl-
2. Greider et al (2002) added further to this work, by reporting that other than Bcl-2, Bcl-






demonstrated that Bcl-2 inhibited E2F-1 induced apoptosis without affecting E2F-1 
induced cell cycle entry, hence illustrating that cell cycle delay is not an inevitable 
consequence of enhanced survival. The delay in S-phase entry is p27 dependent as the 
absence of p27 nullified the phenomenon (Vairo et al., 2000; Greider 2002). Other 
suggested mechanisms of regulation by Bcl-2 include the upregulation of p130 which 
complexes with E2F-4 during G0 to inhibit E2F-2 expression (Lind et al., 1999); and that 
p38 MAPK is necessary for the Bcl-2 induced cell cycle arrest (Nelyudova et al., 2007). 
Previous investigations have revealed that Bcl-xL and Bcl-2 influence cell cycle 
checkpoints as part of the DNA damage response network (Komatsu et al., 2000; 
Saintigny et al., 2001). More recently, phosphorylated Bcl-2 has been found to colocalize 
in the nucleoli with nucleolin, cdk1 (cdc2) and PP1 phosphatase, before mitosis is 
commenced (Barboule et al., 2005). A later study by Schmitt et al. (2007) reported that 
Bcl-xL colocalizes and binds to cdk1 (cdc2) during the G2/M cell cycle checkpoint and 
that overexpression of the protein stabilises G2/M arrest senescence program in the 
surviving cells. The authors suggest that Bcl-xL achieves this by inhibiting cdk1 (cdc2) 
kinase activity. Mcl-1, another Bcl-2 ati-apoptotic protein, was also reported to inhibit 
cell-cycle progression through the S phase of the cell cycle. This function is mediated by 
the interaction between Mcl-1 and proliferating cell nuclear antigen (PCNA), a cell-cycle 
regulator that is crucial in DNA replication (Fujise et al., 2000). Mcl-1 has also been 
reported to colocalize and interact with cdk1 (cdc2) in the nucleus to regulate cell 
proliferation (Jamil et al., 2005). The cell cycle regulatory role of these Bcl-2 family 
members is likely to be distinct and separate from its function in apoptosis, as mutation of 






residue Y22 in Bcl-Xl, eliminated their cell cycle activities but spared their regulation of 
apoptosis (Huang et al., 1997; Vairo et al., 1996). However, Janumyan et al (2003) 
reported conflicting results. They showed that Bcl-2 targeted to ER and mitochondria 
during delayed cell cycle entry, and prolonged G0 during cell cycle entry. This effect was 
reversed by Bad and they were unable to detect a difference between Y28-mutant and 
wild type Bcl-2, in survival or cell cycle studies, thereby concluding the link between the 
anti-apoptotic and cell cycle-regulatory roles of Bcl-2 and Bcl-xL.  
The pro-apoptotic members of the Bcl-2 family have also been shown to have an 
effect on the cell cycle. Zinkel et al (2006) described that Bax accelerates S-phase 
progression, although the underlying mechanism remains to be elucidated. 
1.6 A member of the Bcl-2 family: Diva (death inducerbinding to vBcl-2 and 
Apaf-1)  
Diva was identified as a novel regulator of apoptosis by Inohara et al (1998), 
when they cloned a from the GenBank expressed-sequence tag (EST) which was 
homologous to chicken neuroretina (NR-13). It was found to be a member of the Bcl-2 
family of proteins containing BH1, BH2, BH3, and BH4 regions and a carboxyl-terminal 
hydrophobic domain. However, Diva lacked critical residues that mediate the interaction 
between BH3-containing proapoptotic Bcl-2 homologues and their prosurvival binding 
partners. It was found to only bind to Apaf-1 and vBcl-2, a Bcl-2 homologue encoded by 
the Kaposi's sarcoma-associated herpes virus.  
A year later, another protein that was homologous to NR-13 was also reported. 






as a novel anti-apoptotic protein. Chromosomal localization analysis revealed that Boo is 
on the murine chromosome 9 at band d9. It enhanced cell survival when exposed to 
growth factor deprivation, gamma-irradiation or cyclosporin A. Later, it was found that 
both genes were identical to each other. A human ortholog has also been identified, and 
designated as Bcl-B or Bcl2l10 (Ke et al., 2000). It has been mapped to chromosome 
15q21, a locus recognized to be related to human cervical cancer. Interestingly, 3 out of 
24 human cervical cancer genomic DNA samples displayed deletions within their Bcl-B 
genes, therefore suggesting a role for the protein in the pathogenesis of cervical cancer 
(Lee et al., 2001). Russel et all (2002) generated Diva-null mice and they reported that 
despite the strong presence of Diva in the ovaries and nervous system (Inohara et al., 
1998), these mice were similar to wild type littermates in terms of fertility, behaviour, 
organ development and survival. Naumann et al (2001) reported that Diva-
overexpressing cells were arrested in G1 phase in response to serum deprivation. 
1.6.1 Distribution of Diva 
 In situ hybridisation detected intense Diva mRNA labeling in the brain, liver, and 
heart of E15 embryonic mice. In adult mice, the expression of Diva was restricted to the 
granulosa cells of the ovary and the seminiferous tubules of the testis. Within the tubules, 
Diva was expressed in spermatids but not in spermatogonia, spermatocytes or mature 
spermatozoa (Inohara et al,; 1998). The focal pattern of Diva labelling in seminiferous 
tubules is consistent with a stage-specific expression during spermatogenesis, because the 
plane of the section transects the neighbouring tubules in different stages of the 
spermatogenic cycle. Reverse transcription-PCR analysis of Diva expression concurred 






restricted to reproductive tissues in the adult and differs considerably from that reported 
for other Bcl-2 family members including Bcl-2, Bcl-XL and Bax. 
On the other hand, the expression of Boo was limited to the ovaries and 
epididymis, and has the most restricted tissue distribution of the Bcl-2 family. As Bcl-w 
inactivation leads to reduced size of the testis and seminal vesicles causing sterility (Ross 
et al., 1998) and Bcl-2 overexpression in spermatogonia and also leads to disruption of 
spermatogenesis (Knudson et al., 1995; Furuchi et al., 1996), the expression of Boo in the 
epipidymis may indicate that it contributes to sperm maturation. It was suggested that 
several Bcl-2 homologues with very similar functional properties are necessary during 
different stages of sperm maturation and Boo is likely to be important during the 
epididymal phase. 
1.6.2 Protein interactions of Diva and its apoptotic functions 
Thus far, all reports on Diva/Boo have reported on its effect on apoptosis. 
Contradictory observations have been made and the matter is still under contention. Diva 
forms a ternary complex with apoptosis-activating factor-1 (Apaf-1) and caspase-9, 
components of the apoptosome along with cytochrome c (Song et al., 1999). It acts as a 
proapoptotic member who acts as a competitor of Bcl-XL for Apaf-1 binding and induces 
BH-3 independent cell death (Inohara et al., 1998). The Bcl-B protein, which is widely 
expressed in human tissues, was shown to bind to Bcl-2, Bcl-xL and Bax, but not to Bak. 
Therefore, Bcl-B supresses apoptosis by Bax, but not Bak (Ke et al., 2000). The authors 
attribute the conflicting results of the various studies to the possibility that Bcl-B displays 






expressed in the ovary, testis and epididymis, Bcl-B has widespread expression in the 
adult. This led to authors to suggest that Bcl-B may not represent the human orthologue 
for Diva. These results were supported by Zhai et al., (2008), who also demonstrated that 
co-expression of Bcl-B suppressed Bax-induced apoptosis, but had no effect on Bak- 
induced apoptosis. 
 Kang et al (2007) used the yeast two-hybrid system to search for binding partners 
for Diva. A nucleoside diphosphate kinase isoform, NM23-H2, was identified. Diva 
bound to NM23-H2, with co-localization in the cytoplasm, and the interaction required 
the transmembrane domain of Diva. Diva protein level was demonstrated to be 
significantly down-regulated by NM23-H2 as knock down of NM23-H2 restored Diva 
expression. Overexpression of NM23-H2 induced apoptosis, and the depletion of NM23-
H2 led to the increase of Diva's apoptotic activity. 
On the other hand, Boo was reported to inhibit apoptosis through 
homodimerization or heterodimerization with some pro-apoptotic (bak and bid) and anti-
apoptotic (bcl-2 and bcl-xl) Bcl-2 family members. Interestingly, Boo did not interact 
with endogenous Apaf-1 and there was still no association when under apoptotic stimuli 
(Morishii et al., 1999). Further evidence supporting the anti-apoptotic property of Diva 
came from Weller and co-workers, who reported that Diva/Boo inhibited apoptosis in 
glioma cells induced by CD95 ligand or chemotherapeutic drugs (Naumann et al., 2001). 
In human, the homologue of Diva, Bcl-B, was found to inhibit the Bax induced apoptosis 






1.6.3 Diva may also have functions in cytoskeleton assembly and 
development 
The latest report by Kim et al (2009) identified Hungtington-interacting protein 1-
related (H1P1R) protein as a binding partner for endogenous Bcl2l10 using the yeast two-
hybrid system. As H1P1R is involved in regulating the clathrin-mediated endocytic 
machinery and actin assembly in cells, this interaction suggests for a previously 
undiscovered role for Diva that it may have a role in actin assembly. The authors also 
reported that endogenous Bcl2l10 associates with caspase 9. The previous studies 
reported the association after overexpression (Inohara et al., 1998; Song et al., 1999).  
Another novel function of Bcl2l10 was proposed also in 2009 by Guillemin et al., 
who reported that the protein was important in oocyte maturation, fertility and embryo 
developmental competence. The group reported that the Bcl2l10 is expressed throughout 
oocyte maturation, although its distribution altered according to stage. In germinal 
vesicle-stage, the staining was diffuse in the ooplasm. At the MI-MII transition stage, the 
protein was strongly expressed around the circumference of the oocyte, as well as around 
the MI spindle. In MII oocyte, Bcl2l10 was once again diffusely distribute in the ooplasm 
and in the pericortical region, with colocalization with actin cytoskeleton. When they 
repeated the experiments with antibodies detecting the murine Diva, they obtained a 
similar profile. Interestingly, when the oocytes were exposed to nocodazole, a 
microtubule destabilizing agent, Bcl2l0 presence in the subplasmalemmal was attenuated. 
When paclitaxel, a microtubule stabilizing agent was applied, the protein‘s presence at 
the pericortical region was augmented. Once again, the yeast two-hybrid system was used 






binding protein TCTP was identified. The authors also report that TCTP and Bcl2l10 co-
localized in the subplasmalemmal region and in the dense ring surrounding the meiotic 
apparatus. The 2 proteins were co-localized with α-tubulin too. The authors suggest that 
Bcl2l10 uses TCTP for its translocation within the oocyte at the different stages, since 
disrupting microtubule dynamics changed its subcellular localisation. Also they proposed 
that Bcl2l10 has spatially restricted regulated roles, since the meiotic machinery and 
pericortical cytoplasm are regions surrounded by mitochondria and ER. The 2 regions are 
known to be critical to oocyte development (Blerkom et al., 2006). It was then suggested 
that Bcl2l10 has evolved rapidly from rodents to humans, as the murine and rat Diva 
share 71% amino acid identity whereas the other anti-apoptotic proteins range between 
90-95% homology. Previously, zebrafish Bcl2l10 (NRZ) was shown to be maternally 
expressed and necessary for egg viability and early embryonic development (Arnaud et 
al., 2006). Embryos with nrz knocked-down had disorganized somites and this was due to 
dysregulation of apoptosis. However there was also another apoptosis-independent 
mechanism that Nrz employed to control gastrulation. Nrz knockdown was found to 
significantly increase the expression level of Snail-1, a transcription factor that regulates 
the expression of adhesion proteins during gastrulation (Nieto, 2002). In another paper, 
the same group also reported that Nrz knockdown increased intracellular calcium levels, 
and that resulted in disorganisation of the microtubule network and F-actin 
depolymerisation in the yolk sac. Hence, it provides evidence that Bcl-2 family may act 
as regulators of cytoskeleton dynamics, albeit via calcium signalling (Popgeorgiev et al., 
2011). Similar to Diva, it exhibited an ovary-specific expression (Kratz et al., 2006). The 






(2009) reported that Bcl2l10 is highly expressed in oocytes but its expression decreases 
after the two-cell stage and disappears thereafter. Microinjection of Bcl2l10 double 
stranded RNA into the cytoplasm of germinal vesicle oocytes resulted in a reduction in 
the maturation rate of the oocyte to MII stage. There were spindle abnormalities in the MI 
and MII oocytes. Some oocytes did not express spindles, while those that did had thinner, 
longer and weaker spindles. This could be due to a reduction in α-tubulin expression. 
1.7 Nm23/NDPK 
NM23 family of proteins are nucleoside-diphosphate kinases (NDPK), which are 
housekeeping enzymes needed for transfer of the terminal phosphate of a nucleoside 
triphosphate to a nucleoside diphosphate, thereby maintaining the nucleotide pools. This 
family of highly conserved proteins in eukaryotes are composed of identically folded 
subunits of about 16–17 kDa each, which assemble into their native conformations of 
hexamers or tetramers (Lascu et al., 2000). Out of the ten known human Nm23 family 
genes, Nm23-H1 through Nm23-H8, Nm23-H1 and H2 are the most abundant and 
ubiquitous isoforms (Boissan et al., 2009). They share 88% homology with each other 
and are about 95% and 98% similar to their murine isoforms. Both Nm23-H1 and Nm23-
H2 are localized, 3-4kb apart on chromosome 1721.3 (Backer et al., 1993; Okada et al., 
1994).  Interestingly, in E. coli, the gene encoding NDPK is not essential for viability, 
suggesting that the primary function of NM23/NDPK is not in housekeeping.  In 
addition, existence of multiple Nm23 proteins leads one to question whether they carry 
out redundant NDPK activity or could possibly perform specialized functions that are 






1.7.1 Subcellular localization of Nm23/NDPK 
There are many studies that have proven NM23/NDPKs to be cytoplasmic 
proteins. This is no surprise since they are known to associate with the microtubule and 
intermediate filament networks, as will be discussed in the subsection below. Using 
classical immunocytochemistry and GFP systems, studies have shown a strong, granular 
and filamentous staining in the perinuclear region and diminishing towards the membrane 
(Pinon et al., 1999; Roymans et al., 2000). ―Granum-like‖ structures that were spherical 
and approximate 2 µm in size were also reported to localize near the nucleus. The 
observation that the enzymatically inactive forms of NDPKs did not form the granules 
make it fascinating, albeit the indeterminate nature of the punctiform staining (Bosnar et 
al., 2004). 
 Nm23/NDPKs have also been found to colocalize with antibodies specific with 
protein disulfide isomerase, a constituent of the endoplasmic reticulum (ER), exhibiting a 
reticulate staining (Bosnar et al., 2004). Fan et al (2003) proposed that Nm23-H1 (but not 
Nm23-H2) is a constituent of the SET-complex that is associated with the ER in non-
stimulated cells but later translocates to the nucleus when stimulated. Another piece of 
evidence is that Nm23-H2 (but not NM23-H1) facilitates coat protein complex II 
assembly, which is important for ER-Golgi apparatus trafficking as well as vesicle 
formation from the ER (Kapetanovich et al., 2005). These 2 studies highlight that both 
isoforms have distinct functions with the ER. 
Nm23/NDPKs were also observed to be occasionally in the nucleus, and this is 






and Nm23-H2 can enter the nucleus together (Bosnar et al., 2004), or Nm23-H2 may 
enter selectively (Pinon et al., 1999). Entry into the nucleus may also be specific to the 
cell cycle stage, with evidence for high nuclear expression at late G1 and G2/M phases 
(Bosnar et al., 2004). The authors suggest that NDPKs could be supplying the nucleus 
with dNTPs needed for DNA replication. There can be several other reasons to explain 
why NDPKs might translocate to the nucleus, especially when this happens upon specific 
induction. NDPKs could be involved in DNA repair since nuclear localization of Nm23-
H1 is observed after DNA damage (Kaetzel et al., 2006). Nm23-H2 could be involved in 
vasculoprotective effect of estrogens as it associates with Estrogen Receptor β associated 
protein and localises to the nucleus when stimulated with estrogen (Rayner et al., 2007). 
A recent paper has suggested that not only is the expression level important, but nuclear 
localization may also be critical when correlating NDPK to the invasion and metastatic 
potential of breast cancer (Ismail et al., 2008). 
NM23/NDPKs are also found close to the membrane, implying a possible role in 
cell-extracellular matrix or cell-cell contacts. NM23-H1 interacts with ARF6-GTP, which 
is involved in adherens junction disassembly (Palacios et al., 2002). Both NDPKs 
isoforms also interact with ICAP-α. In particular, during early adhesion Nm23-H2, 
ICAP-α and β1 integrin colocalize on the cell membrane (Fournier et al., 2003). Lastly, 
NM23/NDPKs were found to be localised with AMP-activated kinase, on the apical 
membranes of polarized airway epithelia, suggesting that Nm23/NDPKs participates in 







1.7.2 Functions of Nm23/NDPK 
Apart from its kinase activity, Nm23 has been suggested to be involved in a 
variety of cellular functions including cancer metastasis, differentiation, proliferation, 
gene regulation and apoptosis (Roymans et al, 2002; Amendola, et al., 2001; Gervasi, et 
al., 1996; Lombardi, et al., 2000; Negroni, et al., 2000; Otero, 2000). 
1.7.2.1 Tumour suppressor 
Tumour metastasis is a process involving the spread of primary tumours, thereby 
causing secondary lesions.  It entails the detachment of cells from the primary lesion, 
before the surrounding tissue is invaded. The cells then intravasate into the bloodstream 
or the lymphatic system and eventually extravasate and recolonize in distant tissues.  
Hence, the process requires the change of cellular properties, such as cellular adhesion 
characteristics and cell–cell communication. 
 Nm23 was reported as a tumour metastasis suppressor gene by Steeg et al. (1988) 
who screened cDNA libraries of melanoma cell lines with different metastatic potential.  
The expression of the ‗non-metastatic clone 23‘ gene (termed Nm23-M1) showed a 
strong inverse correlation, and transfection studies causing the overexpression of this 
gene confirmed its anti-metastasis property in breast carcinoma, melanoma and prostate 
cancer (Leone et al., 1993a and 1998; Lim et al., 1998). However, studies on 
neuroblastomas and pancreatic cancer have reported a direct correlation with metastasis 
or staging (Leone et al., 1993b and Ohshio et al., 1997). In summary, the general data 






at advanced stages. Colorectal carcinoma tumours at stage 0-II overexpressed NM23-H1 
and NM23-H2, but expression was lost in stage III-IV tumors. 
 There are several hypotheses for its anti-metastastic characteristic, based on its 
binding partners, which was reviewed by Royman et al. (2002). It appears that its NDPK 
activity is not correlated to its anti-metastatic activity, but instead it is the level of the 
protein that modulates the metastatic potential (Macdonald et al., 1993). NDPKA 
associates with Tiam 1, the specific GEF for Rac1, a member of the Rho family of small 
GTPases which is a key signalling molecule in the modulation of the actin cytoskeleton 
required for transformation (Otsuki et al., 2001 and Hall 1998).  Rac1 and Tiam1 are 
involved in the formation of lamellipodia and cadherin-mediated cell-cell adhesion 
(Sander et al., 1998 and 1999). Therefore by suppressing Tiam 1, Nm23 is able to 
influence the metastatic phenotype by inhibiting processes such as invasion and cell 
motility. 
NDPK associates with Ras (Ohtsuki et al., 1987) directly, or interacts with Ras-
related protein associated with diabetes (Rad). Rad functions as a guanine nucleotide 
exchange factor (GEF) and can regulate Ras activity. It is also an intracellular signal 
transduction molecule functional in cell proliferation and differentiation. Ras and Ras-
related GTPases are reported to have functions in cell proliferation and differentiation 
(Lange-Carter and Johnson, 1994), apoptosis (Evan and Littlewood, 1998), cytoskeletal 
rearrangements (Hall 1994) and cell cycle regulation (Yang et al., 1998). These are all 
integral processes in metastasis and carcinogenesis, and could explain the anti-metastatic 






1.7.2.2. Gene regulation 
Postel et al. (1993) identified Nm23-H2 as PuF, a transcription promoting factor 
of the c-myc oncogene. Both NM23-H1 and NM23-H2 have been identified to bind to 
DNA with transcriptional activity on the PDGF-A chain promoter (Ma et al., 2002). 
These two proteins have demonstrated DNA binding, DNA cleavage, as well as 
transcriptional activity that is independent of phosphoryl transfer and NDPK activity 
(Postel, 2003). A model was proposed to explain how transcriptional regulation was 
controlled by the nuclease-like activity of NDPK. NDPK cleaves both linear and 
supercoiled double stranded DNA, which results in a covalently bound enzyme-DNA 
complex. NDPK then uses the energy from the covalent bond to re-ligate the DNA.  It 
should be noted that although they have the same nuclease property, NDPK A and NDPK 
B have different cleavage positions, which might explain their non-overlapping functions. 
However, it is still unknown if there is a defined consensus sequence for DNA cleavage 
by NDPKs or what are the signals that NDPKs recognize for cleavage. There is some 
evidence for sequence specificity. NDPK B has specific contacts with the repeated 
palindromic sequence GGGTGGG of the c-myc nuclease hypersensitive element (NHE) 
(Ji et al., 1995). Then again, binding of NDPK B can also be less precise, since it binds 
purine-rich and pyrimidine-rich strands of the c-myc NHE, as well as to single and 





 -termini, rather than by a specific nucleotide sequence (Ma et al., 
2002).  
Hence, present data seem to support NDPK to have an accessory function instead 






repressor of transcription hinges on the cell type and the promotor (Berberich et al., 1995; 
Ma et al., 2002). In fact, a study by Michelotti et al (1997) even argues that due to the 
lack of a conventional transcriptional activation domain, NDPK B cannot stimulate 
transcription independently. This is supported by evidence that NDPK binds to EBNA-
3C, which then translocates NDPK A from the cytosol to the nucleus of the cell. Given 
that EBNA-3C is a transcription factor important for the growth transformation of the 
Epstein Barr virus in the host cell, and that it is also able to bind other transcription 
factors such as RBP-Jκ/CBF1 and Sp-1, the authors propose that this interaction could 
thereby regulate the activity of NDPK A as a transcriptional activator/repressor 
(Subramanian et al., 2001). 
What remains clear is that the physiological role of NDPKs in cellular processes 
such as differentiation and metastasis involves its ability to regulate gene transcription. 
There is in vivo evidence that NDPK B induces transcription in Burkitt‘s lymphoma (Ji et 
al., 1995). Postel et al (2000) also showed that Nm23-H2 activated genes involved in 
myeloid differentiation, and it does so through recognition of the c-myc NHE-like 
sequences. 
 In order to delineate the biological significance of NM23 enzymes, nm23-M1 
(which is 88% homologous to nm23-M2 and NM23-H2) was disrupted in mice. This led 
to high mortality rates after birth, premature senescence, reduced birth size, and defects in 
the immune system. This array of phenotypes is known to be associated with DNA repair 
defects (Dabernat et al., 1999). Moreover, nm23-H1 null mice show predisposition to 






2000; Lindahl andWood, 1999; Loeb, 1998; Modrich and Lahue, 1996), and supporting 
the hypothesis that the role of NM23- H1 may be to prevent DNA damage.  
1.7.2.3 Differentiation 
However, out of the eight known human NM23 family genes, NM23-H1 through 
NM23-H8, only H1 to H4 are closely related and known to play critical roles in 
development (Lacombe et al., 2000; Lombardi et al., 2000; Venturelli et al., 1995). 
NM23-H1 and H2 are the most abundant and ubiquitous isoforms, and are located both in 
nuclei and cytoplasm, while H4 is located in mitochondria (Lacombe et al., 2000).  
An early indication of Nm23/NDPK‘s role in differentiation was the observation 
that the Drosophilia melanogaster homologue, awd, is required for proper differentiation 
of epithelial tissues. Extensive abnormalities were seen in null mutations or when there 
was reduced expression of the gene. Embryonic development was normal up until 
metamorphosis, and larvae development has aberrant differentiation and tissue 
morphology, culminating in necrosis of the imaginal discs, brain, and proventriculus 
(Dearolf et al., 1988; Rosengard et al., 1989). Transfection of the wild type awd gene into 
the mutant germline led to restoration of normal differentiation (Timmons et al., 1993).  
Nm23/NDPK has also been studied in murine development and organogenesis. It 
was previously demonstrated that the rodent nm23 genes are highly comparable to 
humans at the level of gene organization, tissue expression, and protein primary structure 
(Mass´e et al., 2002). Lakso et al (1992) reported a low and uniform distribution of the 
Nm23 protein throughout the embryo before organogenesis. At the onset of 






which are the first tissues to differentiate in development. Tissues of epithelial origin are 
next in line to differentiate, and there is a similar increase in Nm23 levels. It is interesting 
that unlike other terminally differentiated tissues, which have consistently high levels of 
Nm23, intestinal epithelia cells only have a transient boost in expression. This could be 
because intestinal epithelial cells are constantly renewed. A similar phenomenon is 
observed in mammary glands.  Nm23 expression is minimal during embryo development, 
but it expression escalates in mid-pregnancy, when there is full differentiation of 
mammary tissue. At the onset of lactation, when mammary tissues are proliferating 
extensively, Nm23 expression subsides once again. The last evidence that suggests a role 
for Nm23 in normal functional differentiation and maintenance of the differentiated state 
is presented in adult ovaries, where protein expression is strong in differentiated corpora 
lutea but suppressed in oocytes. 
A later study by Gervasi et al (1998) analysed the transcripts encoded by Nm23-
M1 gene. The highest level was recorded at 11 days post-coitum, at the onset of 
organogenesis, and decreases at 17 days post-coitum. Interestingly, expression is 
concentrated at the chorionic plate level where the stem cells are thought to be present. In 
adult mouse tissues, there was maximal expression in the brain, liver and kidney. The 
result that Nm23 is possibly involved in nervous tissue differentiation was further 
enriched by Dabernet et al. (1999), who showed that there is preferential expression in 
the adult mouse CNS. 
In vitro cell systems have shed more light on how Nm23 might affect neural 
differentiation. When exposed to differentiation conditions, neuroblastoma cells that had 






with concurrent increase in differentiation-related proteins and properties, including 
modulated integrin levels and cellular adhesion characteristics. DR-nm23 also has a role 
in lineage determination as its ectopic expression induced neuronal and schwannocitic 
differentiation (Amendola et al., 1997). In a later study by the same group, they reported 
that the differentiation-inducing ability of DR-nm23 is dependent on the NDPK activity 
of the protein (Negroni et al., 2000). As mentioned above, Nm23-H1 can inhibit Tiam 1 
activation of Rac1 which inhibited ruffle and lamellipodium formation (Sander et al., 
1999), whereas Nm23-H2 colocalizes with ICAP-1α in lamellipodia and ruffles during 
early stages of cell spreading (Fournier et al., 2003). Another way by which Nm23 
influences cell migration is through modulation of cytoskeletal dynamics. Nm23 proteins 
were found to associate with cytoskeleton proteins such as tubulin, vimentin and glial 
fibrillary acidic protein (GFAP) (Lombardi et al., 1995; Pinon et al., 1999, Otero, 1997). 
While NDPKB colocalizes and complexes with both vimentin and GFAP, the interaction 
between NDPKA and GFAP appears to be exclusive (Roymans et al., 2000). Using 
transfection and anti-sense techniques, Nm23 expression was modulated and this resulted 
in a change in tubulin polymerisation, indicating a regulatory role of Nm23 in tubulin 
polymerisation. This association with tubulin is modulated during cell invasion and 
differentiation, indicating a possible direct involvement of Nm23, or alternatively, a 
recruitment of the protein to pathways regulating cell shape and/or cell motility 
(Lombardi et al., 2002). The reason for the association is likely to be that NDPKs would 
supply GTP to the microtubules to promote their polymerization (Biggs, et al., 1990).  
In addition to neural differentiation, NM23/NDPKs are also involved in 






granulocytic differentiation. There was an inverse relationship between the expression of 
cell differentiation markers and Nm23-H1 in leukemia cell lines, suggesting that the 
protein is important to achieve the differentiated state (Okabe-Kado et al., 1995). In most 
cells of hematopoietic origin, such as bone marrow CD34 positive cells, expression of 
both Nm23 isoforms has been detected and is decreased in more differentiated cell types. 
Venturelli et al (1995) had some differences in their report. They observed that the DR-
nm23 mRNA expression in undifferentiated CD34 positive cells is escalated after IL-3 
and G-CSF induced differentiation. Hence, Willems et al (1998) has proposed that Nm23 
is important in the early stages of hematopoiesis, possibly regulating different stages that 
is subject to the specific cellular lineage. 
1.8 Mesenchymal stem cells (MSCs) transplantation therapy 
MSCs, otherwise known as bone marrow stem cells, are non-hematopoietic 
stromal cells that have the capability to differentiate into mesenchymal tissues such as 
bone, cartilage, muscle, ligament and adipose. Although they are not immortal, they have 
the ability to proliferate in culture while still retaining their multipotentiality. There has 
been a lot of interest in using MSCs for stem cell therapy because of the multiple benefits 
that they provide to the injured CNS. The role of MSCs in neurogenesis and nervous 
system repair has been recently reviewd (Maltman et al., 2011; Ben Hur, 2011). MSC 
therapy has been used in acute injury models including TBI, spinal cord injury (SCI) and 
stroke (Lu et al., 2006; Hofstetter et al., 2002; Li et al., 2005). MSC transplantation 
therapy into neurodegenerative models, such as ALS and PD, has also been investigated 






1.8.1 Benefits of MSC transplantation therapy 
MSCs are able to transdifferenitate in vivo, into neurons, astrocytes, microglia 
and oligodendrocytes, with the specific expression markers of each cell type (Lu et al., 
2006). Therefore MSCs can replace the lost neural cells and aid in functional recovery. 
Other than regeneration, MSCs also provide neuroprotection to surviving neurons by 
reducing apoptosis, inflammation and demyelination. In addition, MSCs release a myriad 
of neurotrophic factors, such nerve growth factor (NGF), brain derived neurotrophic 
factor (BDNF) and glial cell derived neurotrophic factor (GDNF). Recent work has also 
shown that the neurotrophic factors secreted by MSCs provided protection against 
apoptosis, increased survival and promoted neurogenesis (Crigler et al., 2006; Isele et al., 
2007). MSCs can also stimulate the injured brain to secrete BDNF and NGF (Mahmood 
et al., 2004). The presence of NGF and BDNF has been shown to initiate the 
differentiation of BMSCs into neuronal cells (Lu D et al., 2001). Hence, the effect is 
somewhat synergistic, as MSCs alter the niche environment to create a favourable 
environment for themselves. Other reported benefits of MSC transplantation includes 
remyelination, repair of the blood brain barrier and angiogenesis (Akiyama et al. 2002, 
Chen et al., 2004). 
There are many advantages of using MSCs as compared to the other stem cells, 
such as neural stem cells. The main advantage is that the immune phenotype of MSCs, 
which is characterized as MHC I+, MHC II-, CD40-, CD80-, CD86-, is regarded as non-
immunogenic and, therefore transplantation into an allogeneic host may not require 






procedures, and rapidly expanded ex vivo, while maintaining their potentiality (Le Blanc 
et al., 2003; Aggarwal and Pittenger, 2005).  
An imperative first step when considering a cell type for use in regenerative 
medicine is to determine if the cell is able to migrate, engraft and survive at damage sites, 
Transplanted MSCs have been shown to migrate to the sites of injury and provide 
beneficial effects (Parr et al., 1997). Other studies have also reported observation of 
MSCs found in different consecutive layers up to 72 days post-translation, including in 
higher order primates (Deng et al., 2006). 
1.8.2 Issues with MSC transplantation therapy 
An actively ongoing aspect of MSC research is to drive its differentiation towards 
a neuronal lineage in vitro before transplantation. The pre-differentiation of MSCs would 
most likely enhance its ability to anatomically and functionally integrate into the brain, 
thereby providing higher efficacy in ameliorating lesions. In addition, differentiated 
neural cells are generally considered to have a lower chance of forming tumours as 
compared to actively dividing precursors. 
The efforts to cause in vitro differentiation of MSCs have been excellently 
reviewed by Chen et al. (2006). Methods include co-culturing with neural cells (e.g., 
astrocytes and neural stem cells), transfection followed by treatment with neurotrophic 
factors and induction using simple chemicals (e.g. retinoic acid and β-Mercaptoethanol). 
However, even as the morphology and protein expression of the transdifferentiated cells 
are similar to neurons, it is still unsure unclear whether these transdifferentiated cells 






1.9 Scope of study 
Molecular linkages between cell death, cell survival and cell cycle have been at 
the centre of intense research, as delineated above. There is increasing evidence that the 
Bcl-2 family has distinct roles in both differentiation and the cell cycle. Thus far, the 
physiological role of Diva has remained elusive due to a paucity of information. Even its  
function in apoptosis is highly controversial with many opposing reports. Diva is known 
to interact with Nm23-H2/ NDPK B, and has a decreased expression pattern during 
development. These findings suggest its involvement in differentiation, which this study 
aimed to investigate. In particular, the relationship between Diva and Nm23-H2/ NDPK 
B proteins will be examined. Murine NSC-34 cells (a motor neuronal cell line), as well as 
rat pheochromocytoma PC-12 cells (a neuronal model of differentiation) and primary 
mesenchymal stem cells were utilized as models of differentiation as preliminary results 
showed that these cells contain endogenous Diva. For ease of terminology, NDPK B, a 
more generic term used to represent NM23-H2 for the different organisms, is used for the 
rest of the project. 
The hypothesis of this study is that Diva might have a role in differentiation and cell 
cycle regulation, and this role is likely to involve NDPK B. It is hypothesized that the 
neurite outgrowth of the cells will be altered by Diva and NDPK B, and that it will 
involve interaction with cytoskeletal proteins, which NDPK B has been shown to 
associate with. The aims of this project are therefore as such: 







2. To investigate the functional roles of Diva and NDPK B in differentiation and cell 
cycle regulation 
3. Elucidating the molecular mechanisms underlying these effects, especially the 
expression of cell cycle regulators such as cyclins, CDKs and CDKIs.























In summary, the experimental plan to investigate the aims of the project was to 
differentiate the PC-12 and NSC-34 cell lines and then analyze their time-dependent 
expression of Diva and NDPK B expressions. Thereafter, both proteins would be 
overexpressed in the PC-12 cell line and examined for their ability to affect neuronal 
differentiation by altering the percentage of differentiated cells, average neurite length as 
well as their effects on cell cycle regulation. The primary mesenchymal stem cells would 
also be transfected with the Diva and NDPK B plasmids in order to observe if the 
proteins could affect MSC differentiation as well.   
2.1 Tissue cell culture 
After screening, PC-12 and NSC-34 cell lines, as well as primary mesenchymal 
stem cells were used in the study because these cell types were found to contain 
endogenous Diva.  PC-12 cell line and NSC-34 cell lines have both been shown to exhibit 
neuronal properties after induction (Heumann et al., 1984; Cashman et al., 1992) and 
were therefore used as models of differentiation that were employed to determine the 
expression of Diva and NDPK expression during the course of differentiation.  
2.1.1 PC-12 cell line 
PC-12 cell line is established from rat adrenal medullary pheochromocytoma.  
PC-12 cells are 6-14 μm in diameter, round, catecholamine-containing cells that have a 
doubling time of between 48 and 96 hr. Unlike the adrenal medulla, in which 
norepinephrine is the major catecholamine, the PC-12 cells contain primarily dopamine, 
and norepinephrine in much lesser amounts. Choline acetyltransferase is found in PC-12 





cells (Schubert et al., 1977) and its induction by NGF has been studied (Heumann et al., 
1984).  
2.1.1.1 Maintenance of PC-12 cell line 
PC-12 cells were routinely maintained at 37°C and 5% CO2 in DMEM (Sigma, 
USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Hyclone, 
Germany).   
2.1.1.2 Differentiation of PC-12 cell line 
Upon addition of nerve growth factor (NGF) into the medium, PC-12 cells stop 
dividing and develop elaborate and branched processes. Removal of NGF leads to 
degeneration of processes and cells resume division. 
 50ng/ml of NGF (Invitrogen) was added to DMEM with 1% FBS (differentiating 
medium). The differentiating medium was then either added to 1x10
6
 cells in a flask (for 
real-time PCR and immunoprecipitation studies), or 5x10
5
 cells in a well (for 
immunocytochemistry studies). The media was replaced with fresh differentiating 
medium every other day. 
2.1.2 NSC-34 cell line 
The Neuroblastoma x Spinal Cord (NSC) cell line was first developed by 
Cashman et al (1992) by fusing neuroblastoma N18TG2 with motor neuron-enriched 
embryonic day 12-14 spinal cord cells. The NSC-34 cell line expresses properties 
expected of motor neurons such as generation of action potential, expression of 





neurofilaments as well as acetylcholine synthesis and release, and is thus categorized as a 
motor neuron cell line. 
2.1.2.1 Maintenance of NSC-34 cell line 
NSC-34 cells were routinely maintained at 37°C and 5% CO2 in DMEM (Sigma, 
USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Hyclone, 
Germany).   
2.1.2.2 Differentiation of NSC-34 cell line 
The NSC-34 cells were seeded 1x10
6
 cells in a flask (for real-time PCR and 
western blot studies). They were then placed in the differentiating medium consisting of 
DMEM F12 (Invitrogen, USA), 1% FBS and 1% streptomycin. The media was replaced 
with fresh differentiating medium every other day. 
2.1.3 Isolation of rat mesenchymal stem cells (MSCs) 
Sprague-Dawley rats were euthanasized in a carbon dioxide chamber. The MSC 
isolation protocol was as mentioned in Soleimani and Nadri (2009). The MSCs were 
collected from the tibia and femoral bone marrow by inserting a 26-gauge syringe at bone 
cavity, washing it with DMEM. The cell suspension was filtered through a 70mm filter 
mesh to remove any bone spicules or muscle clumps. The MSCs were then cultured at a 
density of 25 x 10
6
 cells/ml in 95 mm culture dishes and incubated for 3 hours at 5% CO2 
and 37°C. The non-adherent cells were then removed by replacement with fresh medium. 
After an additional 8 hours, the medium was replaced again. This step was repeated every 
8 hours for up to 72 hours in culture. The adherent cells (passage 0) were washed with 





PBS and fresh medium was added every 3 days. After 2 weeks of initiating culture, the 
cells were washed with PBS and the cells were lifted by 0.25% trypsin/ 1 mM 
ethylenediaminetetraacetic acid for 2 minutes at room temperature. Complete medium 
was added to neutralise the trypsin and the lifted cells were cultured into a 25cm
3
 flask. 
The medium was changed every 3 days and the population of MSCs was obtained. The 
rat MSCs were obtained with a protocol and procedures approved by the Institutional 
IACUC. 
3.1.3.1 Maintenance of MSCs 
The MSCs were routinely maintained at 37°C and 5% CO2 in DMEM (Sigma, 
USA) supplemented with 20% heat-inactivated fetal bovine serum (FBS) (Hyclone, 
Germany). 
 2.1.3.2 Characterization of MSCs 
 The MSCs were seeded onto coverslips at 2 x 10
5 
cells in a 6 well plate and 
cultured for a day before they were characterised using Mesenchymal Stem Cell 
Characterization Kit (Millipore, USA). In brief, the medium was aspirated and the cells 
were fixed with 4% PF for 10 minutes. The fixative was aspirated and the cells were 
washed with 1X PBS for 3 times. The cells were blocked with 5% donkey serum, 0.3% 
Triton X-100 in 1X PBS for 2 hours at room temperature, before incubation with 
antibodies against fibronectin, collagen and intergrin β1, overnight at 4°C. The Non-
permeable blocking solution (5% donkey serum in 1X PBS) was used with cellular 
differentiation antibodies (CD54, CD45and CD14).   





Table 2.1 Antibodies used for stem cell characterization 
Antibody Dilution 
Rabbit integrin β1 1:500 
Mouse anti-CD 54  1:100 
Rabbit anti-collagen Type 1 1:500 
Rabbit anti-fibronectin 1:1000 
Mouse anti-CD14 Negative staining at 1:100 
Mouse anti-CD45 Negative staining at 1:100 
 
The next day, the cells were washed 4 times with 1X PBS. After the last wash, 
block the samples with non-permeable blocking solution for 30 minutes at room 
temperature. The samples were then incubated with their secondary antibodies, anti-
mouse FITC or anti-rabbit Cy3, at a concentration of 1:200 for 1 hour at room 
temperature. The cells were then washed with 0.1% PBS-Triton X for 3 times of 5 
minutes each, before they were mounted onto glass slides with Vectashield Mounting 
Medium with DAPI (Vector Labs, USA). 
2.1.3.3 Osteogenic differentiation of MSCs (Invitrogen) 
MSC growth medium 
445mL DMEM low glucose 





50 mL MSC-qualified FBS 
5 ml GLUTAMAX-I 
250 µl Gentamicin 
Osteogenesis differentiation medium 
90 mL STEMPRO Osteocyte/Chrondrocyte differentiation Basal Medium 
10 mL STEMPRO Osteogenesis Supplement 
50 µl Gentamicin 
The cells were seeded at 2 x 10
5
 cells and allowed to culture for 24 hours, by 
which they reached a confluence of 70%. The medium was aspirated and the cells were 
washed with 1X PBS. The cells were then trypsinised for 5 minutes in an incubator at 5% 
CO2 and 37°C. 10% DMEM was then added, before the solution was pipetted into 
centrifuge tubes and cells were pelleted at 100 x g for 5 min. The pellet was then 





 in MSC growth medium and incubated for 2 hours at 5% CO2 and 37°C. 
The media was then aspirated and replace with pre-warmed osteogenesis differentiation 
medium and incubation was continued. The culture was refed every 3 days, for 21 days 
before they were stained with Alizarin Red S Stain Analysis. 
2.1.3.4 Chondrogenic differentiation of MSCs (Invitrogen) 
MSC attachment medium 
89mL DMEM low glucose 





10 mL MSC-qualified FBS 
1 mL GLUTAMAX-I 
50 µL Gentamicin 
Chondrogenesis differentiation medium 
90 mL STEMPRO Osteocyte/Chrondrocyte differentiation Basal Medium 
10 mL STEMPRO Chondrogenesis Supplement 
50 µl Gentamicin 
The steps are the same as osteogenesis until the pellet is obtained. Next, the cells 
were resuspended in MSC attachment media to generate a cell solution of 1.6x10
7
 
cells/ml. Micromass cultures were obtained by seeding 5 µl droplets of cell solution in 
the centre of the coverslip. After cultivating micromass cultures for 2 hours in an 
incubator at 5% CO2 and 37°C, the medium was aspirated and replaced with 
chrondrogenesis media. The culture was re-fed every 3 days. After 14 days, the 
chondrogenic pellets were processed for Alcian Blue staining. 
2.1.4 Cryopreservation of cells 
To ensure a constant supply of cells for experimental usage, the cells were 
cryopreserved in liquid nitrogen. In brief, trypsinized cells were centrifuged at 125 g for 5 
min at 4°C and the cell pellet was resuspended with medium containing 20% FBS and 
10% DMSO before ampules (Nagle Nunc, Roskilde, Denmark) containing 5 x 10
5
 cells 
were transferred to 5100 Cryo 1°C (Nagle Nunc) freezing container at -70°C to be stored 





overnight, The next day, the ampules were immersed at liquid nitrogen for long term 
storage. 
2.2 Real-time Polymerase Chain Reaction (RT-PCR) 
RT-PCR was used to study gene expressions of the different genes, in order to 
elucidate if there was transcriptional regulation of the genes. The expression profiles of 
Diva and NDPK B proteins during the course of differentiation were examined. β III-
tubulin was used as a marker for differentiation.  
2.2.1 RNA isolation 
After differentiation, total RNA was isolated from the cells in each well of a 6-
well plate using the RNeasy Mini kit according to the manufacturer‘s protocol (Qiagen, 
USA). Briefly, after washing with PBS for two times, the cell pellets were lysed in 500μl 
of Buffer RLT (provided with the kit, containing a highly denaturing guanidinium 
isothiocyanate which immediately inactivates RNase). 10 μl β-Mercaptoethanol (β-ME) 
was added to every 1ml of Buffer RLT before use. After the lysate was passed through a 
22G needle for ten times, 500µl of 70% ethanol was then added to the cleared lysate and 
mixed well to provide appropriate binding conditions. Then the samples were applied to 
an RNeasy mini spin column (silica-gel membrane, maximum binding capacity is 100µg 
of RNA longer than 200 bases), spun for 15 seconds at 10,000g and the flow through was 
discarded. During this step, the total RNA binds to the membrane. The RNA bound to the 
membrane was washed with buffer RW1 and RPE (supplied in the kit) sequentially. 
High-quality RNA was then eluted in 30µl of RNase free water. The concentration and 





purity of the extracted RNA were evaluated by spectrophotometric absorbance readings 
at 260nm and 280nm (Nanodrop Thermoscientific). 
2.2.2 cDNA synthesis 
Two μg of RNA sample was mixed with 2 μl oligo(dT) 15 primer (Promega, 
USA) and DEPC water to make a final volume of 15 μl. After incubation at 70°C for 5 
min, the vials containing the mixture solution were immediately transferred onto ice to 
cool down for 5 minutes. 
Five μl M-MLV Reverse Transcriptase 5X Buffer (Promega, USA) was mixed 
with 1.25 μl dNTP Mix (Promega, USA), 0.675 μl RNase inhibitor (Promega, USA) and  
1 μl M-MLV Reverse Transcriptase(Promega, USA). The mixture solution containing 
RNA sample was transferred into a new vial and incubated at 42°C for 1 hour, following 
by 5-minute incubation at 90°C. 
2.2.3 RT-PCR 
The RT-PCR was performed using a LightCycler instrument (Roche, Mannheim, 
Germany) for 45 cycles of denaturation at 95°C for 10 seconds, annealing at 55°C for 5 
seconds and elongation at 72°C for 8 seconds. Each reverse transcriptase product (1 µl) 
was amplified in the reaction mixture (10 µl) containing 3 µl LightCycler-FastStart DNA 
Master
PLUS
 SYBR Green I mix (Roche), 5 µl of RNase free water and 0.5µl of each 
primers (10µM). The level of specific mRNA was quantified, expressed as Ct, the cycle 
number at which the LightCycler System detected the upstroke of the exponential phase 





of PCR product accumulation, and normalized by the level of GAPDH expression in each 
individual sample (Fields and Casey, 1997). 
Table 2.2 Primers used for quantitative RT-PCR 
Name of primer Sequence 
GAPDH Forward agtctactggcgtcttcacca 
GAPDH Reverse agttgtcatggatgaccttgg 
Diva Forward acggctgctgactgactacat 
Diva Reverse actcttggtcattggagagca 
NDPK B Forward gagatcatcaagcgattcgag 
NDPK B Reverse cctgttttcaccacattgagc 
β-tubulin Forward caagatgtcgtccaccttcat 
β-tubulin Reverse ctcagacaccaggtcgttcat 
Cyclin D1 Forward ctggaccgtttcttgtctctg 
Cyclin D1 Reverse gagcttgttcaccagaagcag 
Cyclin D3 Forward tggtcaaaaagcatgctcag 
Cyclin D3 Reverse gtccacttcagtgcctgtga 
p15 Forward cacggagcagaacccaac 
p15 Reverse cgtgcagatacctcgcaata 
p27 Forward cagaatcataagcccctggag 
p27 Reverse agagtttgcctgagacccaat 
RB Forward gcctcctaccttgtcaccaa 
RB Reverse tgattcaccgattgagacca 
E2F-1 Forward aggaaagtgcagaggggatt 
E2F-1 Reverse cctcaggttgcctattcgag 
 





2.3 Immunofluorescence staining 
Immunofluorescence technique allows the visualization of protein expression in a 
cell, thereby allowing analysis of protein localization and quantity. The cells were seeded 
onto sterilised cover slips placed in a 6-well plate. After differentiation, the cells were 
washed with PBS twice before fixation with 4 % paraformaldehyde for 10 minutes. Next, 
the cells were washed twice each with PBS and 0.1% PBS-Triton X respectively, before 
incubation with 5 % horse serum for 1 hour at room temperature. Subsequently, the cells 
were incubated with primary antibody at room temperature for 2 hours with gentle 
shaking. The cells were then washed with 0.1% PBS-Triton X for 3 times of 5 minutes 
each, before incubation with their secondary antibodies for 1 hour at room temperature. 
The cells were then washed with 0.1% PBS-Triton X for 3 times of 5 minutes each, 
before they were mounted onto glass slides with Vectashield Mounting Medium with 
DAPI (Vector Labs, USA) and photos were taken with a confocal microscope 
(Fluoview1000, Olympus, Japan). 
Table 2.3 Antibody Dilutions for Immunofluoresence 
Primary antibody Antibody Dilution Secondary antibody Antibody dilution 
Diva  
(Santa Cruz) 




NDPK B  
(Santa Cruz) 















Notch-1 1:100 Donkey anti-rabbit 
IgG 
1:200 
NSE 1:100 Donkey anti-rabbit 
IgG 
1:200 




2.4 Taxol treatment 
The purpose of treating the cells with taxol was to ascertain if stabilization of 
microtubules would result in a greater number of NDPK B and β-tubulin complexes, 
hence providing evidence that NDPK B/β-tubulin complex is involved in microtubule 
polymerization. Taxol, otherwise known as paclitaxel, is a plant alkaloid that induces 
microtubule acetylation and polymerization (Nuydens et al., 2000). 24 hrs after plating, 
the control cells were incubated with only 25ng/ml of taxol, whereas the differentiated 
cells were treated with cocktail of NGF and taxol in an incubator at 37°C and 5% CO2 for 
48 hours. Thereafter, the cells were lysed and harvested for co-immunoprecipitation 
studies. 
2.5 Co-immunoprecipitation and Immunoblotting 
In order to study the interaction between proteins, co-immunoprecipitation was 
employed to pull down the protein of interest with its binding partners. Thereafter, 
immunoblotting was used to analyze the relative amounts of the proteins. 
 
 





2.5.1 Protein extraction 
Culture medium was carefully removed from the adherent cells and the cells were 
washed with PBS twice.  1 µl of Halt
TM
.Protease Inhibitor Cocktail (Pierce, USA) and 
EDTA solution 100X (Pierce, USA) were added to every 100 µl of M-PER® Mammalian 
Protein Extraction Reagent (#78501, Pierce, USA) to form the lysis buffer. 300 µl of lysis 
buffer was added to the flasks and shaken gently for 5 minutes. The lysate was collected 
and transferred to a microcentrifuge tube. The samples were cententrifuged at 14,000×g 
for 10 minutes and the supernatant was aliquoted into small vials.     
2.5.2 Protein concentration analysis 
A standard curve for protein concentration was made by using Bio-Rad Protein 
Assay Standard Lyophilized Bovine Serum (1.25mg/ml) (Bio-Rad, USA). The standard 
protein was diluted with distilled water into 0.5, 0.25, 0.125, 0.0625 and 0.03125 mg/ml 
in wells of 96-well plate. The final volume was 10 μl for each concentration. 200 μl of 
diluted Bio-Rad Protein Assay Dye reagent Concentrate (1:5) (BioRad, USA) were added 
into each well containing the standard protein. The mixture was incubated at room 
temperature for 5 minutes and then the absorbance was measured at 595nm in GENios 
plate reader (Tecan Group Ltd, Mannedorf, Switzerland).  
Protein samples were diluted into different concentrations and incubated with 
protein dye for 5 minutes. An appropriate concentration of the samples (whose color 
density was close to that of the 0.125 standard protein with protein dye) was selected to 
measurement of the absorbance at 595 nm. The concentrations of the samples then were 
calculated according to the standard curve. 






Wash buffer : 
50mM Hepes (Sigma) 
150mM Sodium Chloride (Sigma) 
10% Glycerol (Sigma) 
1% Triton X (Sigma) 
1.5mM Magnesium chloride (Sigma) 
1mM EDTA (Pierce, USA) 
10mM Sodium pyrophosphate (Sigma) 
100mM Sodium Fluoride (Sigma) 
2mM Sodium Vanadate (Sigma) 
20 μg/ml of Protease Inhibitor (Pierce, USA) 
The protein samples were diluted with lysis buffer to a final concentration of 
0.68mg/ml. 2 μl of either Diva, NDPK B or β-tubulin antibody was added to 200 μl of 
diluted cell lysate and vortexed . The mixture was incubated overnight at 4°C with gentle 
rocking. 20 μl of Protein G Plus/Protein A-Agarose (Calbiochem, USA) was added to the 
mixture and rocked gently for 3 hrs at 4°C. The mixture was microcentrifuged for 1 
minute at 15,000g and the supernatant was discarded with careful pipetting. 200 μl wash 
buffer was added to the pellet, vortexed, microcentrifuged for 1 minute at 15,000g, and 





the supernatant was discarded with careful pipetting. The washing step was repeated 5 
times, with the samples kept on ice during washes. The pellet was resuspended with 15 μl 
of 6x SDS buffer, vortexed, microcentrifuged for 1 minute at 15,000g and heated at 
100°C for 5 minutes. After microcentrifuging for 1 minute at 15,000g, the samples are 
ready to load. 
2.5.4 Preparation of sodium dodecyl sulphate polyacrylamide gel 
A 12% separating gel was cast using 3.3ml of water, 4ml of 30% Acrylamide/Bis 
Solution (Bio-Rad, USA), 2.5ml of 1.5 M Tris pH 8.8, 0.1ml of 10% (W/V) SDS solution 
(1
st
 Base Singapore), 0.1ml of Ammonium persulfate (Bio-Rad, USA) and 0.004ml of 
N,N‘-methylene bisacrylamide N,N,N,N-Tetramethylenediamine (TEMED) (Bio-Rad, 
USA). The separating gel was injected slowly into the gap of two pieces of glasses 
immediately after adding TEMED. Then 100% alcohol was added to fill up with the 
glasses to get rid of any bubbles. The gel was kept at room temperature for 20 minutes 
until it became solidified. 
A 4% Stacking gel was cast using 3.4ml of water, 0.83ml of 30% Acrylamide/Bis 
Solution (Bio-Rad, USA), 0.63ml of 1.0 M Tris pH 6.8, 0.05ml of 10% (W/V) SDS 
solution (1
st
 Base Singapore), 0.05ml of Ammonium persulfate (Bio-Rad, USA) and 
0.005ml of N,N‘-methylene bisacrylamide N,N,N,N-Tetramethylenediamine (TEMED) 
(Bio-Rad, USA). The alcohol was removed and the stacking gel was injected slowly into 
the gap immediately after adding TEMED. A 10-well comb was inserted into the stacking 
gel immediately after adding the gel solution. The gel was kept at room temperature for 
20 minutes until it became solid. 





 2.5.5 Protein separation on SDS-PAGE 
The glasses containing the gels were transferred into an electrophoresis tank (Bio-
Rad, USA). The combs were removed from the gels and electrophoresis buffer 
(1.51g/litre Tris base, 5g/litre SDS, 7.2g/litre Glycine) was added into the tank. 5μl 
Precision Plus Protein TM Standards (Dual Color) and denatured protein samples were 
added into the wells. Electrophoresis was started at 100 V for 120 minutes. 
 2.5.6 Transfer of protein 
Six Extra Thick Blot Paper Protean® (Bio-Rad, USA) filter papers (for 2 gels) 
with transfer buffer (3.03g/litre Tris, 14.4g/litre Glycine, 200ml Methanol, 800ml 
distilled water) for 30 mins were incubated. 2 Immun-Blot PVDF Membranes (Bio-Rad, 
USA) were incubated with methanol for 10 seconds and then with transfer buffer for 15 
minutes. The gels were separated from the glasses and kept into transfer buffer. From the 
plate of the Semi-dry transfer machine, 1 filter paper, 1 membrane, 1 gel, 2 filter papers 
were placed in sequence and then the proteins were semi-dry transferred at 20V for 1 hr.  
 2.5.7 Immunoblotting 
The membranes were incubated with 5% Blotting grade Blocker Non-Fat Dry 
Milk (Biorad, USA) on a shaker at room temperature for 1 hour and then washed with 
0.1% TBS-Tween twice. The membranes with TBS-Tween diluted primary antibodies 
were incubated on a shaker at 4°C overnight. The membranes were washed with TBS-
Tween on a shaker at room temperature for 3 times of 15 minutes each and then 





incubated with TBS-Tween diluted HRP-secondary antibodies on a shaker for 1 hour at 
room temperature. 
The membranes were washed with TBS-Tween on a shaker at room temperature 
for 3 times of 15 minutes each. Equal volumes of Supersignal® West Dura Extended 
Duration Substrate (Substrate A and B) (Pierce, USA) were mixed and was incubated for 
5 minutes at room temperature. The substrate mixture then was added on the membranes 
and incubated for 1 minute. Next, the membranes were exposed to CL-XPosureTM Film 
18X24 cm Clear Blue X-Ray film (Pierce, USA) for 1min and re-exposed according to 
the intensity of signals. If the signals were too strong (background too high), exposure 
time was reduced accordingly. If the signals are too weak, exposure time was increased. 
If necessary, the membranes were washed with TBS-Tween for 2 times of 15 minutes 
each, before they were stripped by incubating with Restore
TM
 Western Blot Stripping 
Buffer (Pierce, USA) for 30 minutes. After a further 3 washes with TBS-Tween for 15 
minutes each, the membranes were blocked with 5% milk and  reprobed with antibodies. 
Table 2.4 Antibody dilutions for Western Blot procedures 
Primary antibody Antibody Dilution Secondary antibody Antibody dilution 
Diva 
(Santa Cruz) 
1:1000 Donkey Anti-Goat 




1:1000 Goat Anti-rabbit 




1:1000 Goat Anti-rabbit 
IgG HRP Antibody 
1:1000 
β-actin 1:5000 Horse Anti-mouse 1:10 000 





(Sigma-aldrich) IgG, HRP Antibody 
Cyclin D1 
(Cell signalling) 
1:1000 Horse Anti-mouse 




1:1000 Horse Anti-mouse 




1:500 Goat Anti-rabbit 




1:1000 Goat Anti-rabbit 




1:1000 Goat Anti-rabbit 




1:250 Donkey Anti-Goat 




As a complementary technique to co-immunoprecipitation, the Duolink kit was 
also used to study the interaction between the proteins. The Duolink Kit I (Olink 
Bioscience, Sweden) is an in-situ proximity ligation assay used for the detection, 
visualisation and quantification of protein interactions in cell samples prepared for 
microscopy. The principle is that samples that have been incubated with primary 
antibodies from 2 different sources are then incubated with secondary antibodies 
conjugated with oligonucleotides (PLA probe minus and PLA probe plus). The 
Hybridisation solution will only hybridise the 2 probes if they are in close proximity. The 
ligation solution will join the hybridised oligonucleotides into a closed circle. The 





oligonucleotide arm of one of the PLA probes acts as a primer for a rolling circle 
amplification (RCA) using the ligated circle as template. This generates a concatemeric 
(repeated sequence) product. Fluorescently labelled oligonucleotides in the detection 
solution will hybridise to it and become visualised as a fluorescent dot. 
TBS-T wash buffer (pH 7.4): 
8.8g NaCl 
1.2g Tris 
0.5 ml Tween 20  
1L high purity water 
SSC Wash buffer (pH 7.0) 
17.5g NaCl 
8.8g Sodium citrate (tri basic, di hydrate) 
1L high purity water 
In brief, the wild type, pcDNA6A, pcDNA6A-Diva and pcDNA6A-NDPK B cells 
were seeded onto 24 well cover slips at 1 x 10
4
 cell density, and treated with NGF for a 
day. The cells were then fixed in 4% PF for 10 minutes, before the PF was removed and 
they were washed in 1X PBS for 3 times. The 5X blocking stock provided in the kit was 
first diluted 1:5 in high purity water and vortexed before addition to samples. The cells 
were then incubated with 1X Duolink blocking stock for 1 hour, before overnight 
incubation at 4°C with the primary antibodies that were diluted in 1:100 ratio (NDPK B, 





Diva, β-tubulin). The 5X antibody diluent stock provided was diluted and both the anti-
goat-plus and anti-rabbit-minus PLA probes were added to the diluent in 1:10 ratio. Next, 
the cells were washed with 1X PBS for 3 times, and the diluted PLA probes were 
incubated with the samples in a humidity chamber for 2 hours at 37°C. The Duolink 5X 
hybridisation stock was diluted 1:5 in high purity water and mixed. The PLA probe 
solution was tapped off from the coverslips and the coverslips were washed in TBS-T for 
2 x 5 minutes. The hybridisation solution was added and the samples were incubated for 
15 minutes at 37°C. The Duolink 5X Ligation stock was diluted 1:5 in high purity water 
and mixed. The excess Hybridisation solution was tapped off and the coverslips were 
washed in 1X TBS-T for 1 min under gentle agitation. Add Duolink Ligase to the ligation 
solution at 1:40 dilution, just before addition to the samples, and incubate for 15 minutes 
at 37°C. The Duolink 5X Amplification stock was diluted in 1:5 in high purity water and 
mixed. Excess ligation solution was removed and the coverslips were washed in 1XTBS-
T for 2 x 2 minutes under gentle agitation. The excess wash solution was also tapped off 
after the last washing. Duolink Polymerase was added to the diluted amplification 
solution at 1:80 dilution and vortexed, before addition to samples and incubation for 90 
minutes at 37°C. Henceforth, all steps in the Duolink protocol is light sensitive and the 
samples and reagents were kept protected from light. The Duolink 5X Detection stock 
was diluted 1:5 in high purity water and mixed. The amplification solution was tapped off 
from the slides, which were then washed with 1X TBS-T for 2 x 2 minutes under gentle 
agitation. The detection solution was added to the samples and incubated for 60 minutes 
at 37°C. The slides were then washed in 2xSSC for 2minutes, 1x SSC for 2 minutes, 0.2x 
SSC for 2 minutes, 0.02x SSC for 2 minutes and 70% ethanol for 1 minute before the 





samples were left to dry. The coverslips were then mounted on slides using Vectashield 
Mounting Medium with DAPI (Vector Labs, USA).  The cells were then examined using 
confocal microscopy (Fluoview1000, Olympus, Japan). The PLA signal is recognized as 
a discrete fluorescent dot. Image analysis was done using BlobFinder (Centre for Image 
Analysis, Uppsala University), which obtains the number of cells and signals per image. 
2.7 Over-expression studies 
In order to study if the regulation of Diva and NDPK B expressions were a cause 
or consequence of differentiation, the proteins were overexpressed. Therefore, this would 
allow the elucidation of the functions of Diva and NDPK B in differentiation. 
2.7.1 Manufacture of Diva-overexpressing and NDPK B-overexpressing 
plasmids 
The plasmids from Blue Heron Biotechnology company were used. The open 
reading frame (ORF) of Diva and NDPK B were cloned into the mammalian expression 
plasmid pcDNA6A/myc-His© (Invitrogen, USA) containing a human cytomegalovirus 
immediate-early (CMV) promoter which is able to overproduce recombinant proteins 
with a myc and/or poly-His-tag in mammalian cell line. 
2.7.2 Transformation of DH5α competent cells 
 pcDNA6A, pcDNA6A-Diva and pcDNA6A-NDPK B plasmids were transformed 
into DH5α competent cells (Invitrogen, USA) for selection and upscaling. The competent 
cells were thawed on wet ice. 10μl of DNA was mixed with 50μl of competent cells and 
incubated on ice for 30 minutes. After heat-shock at 42°C for 45 seconds in a water bath, 





the cells were placed on ice for 2 minutes. Then 500μl LB medium was added into the 
cells and the cells were shaken at 225rpm for 1 hour to be recovered. After 1 hour of 
shaking, the cells were plated onto the LB plate containing 50μg/ml ampicillin and 
incubated at 37°C for 12-16 hours.   
2.7.3 Extraction of plasmid from transformed DH5α 
The single colony from the selective LB plate was picked up and a starter culture 
was inoculated in 5 ml LB medium containing 50μg/ml ampicillin for 8 h at 37°C with 
vigorous shaking at 300rpm.  After 8 hour incubation, the 5ml of culture was transferred 
into 100ml LB medium containing the 50μg/ml ampicillin in a flask and incubated 
overnight at 250rpm. The plasmid was extracted using QiaGen High Speed Midi Kit 
(QiaGen, USA) following the manufacturer‘s instruction. Briefly, cells in 100ml LB 
medium were harvested by centrifuge at 6000g for 15 minutes at 4°C.  RNAse A was 
added to Buffer P1 before use. The bacterial pellet was resuspended in 4 ml buffer P1 
(supplied in the kit), before 4 ml buffer P2 (supplied in the kit) was added. The contents 
were mixed thoroughly by vigorously inverting the sealed tube for 4 to 6 times and 
incubated at room temperature for 5 minutes.  Then 4 ml of chilled buffer P3 (supplied in 
the kit) was added into the lysate and mixed immediately and thoroughly by vigorously 
inverting the tube for 4 to 6 times. The tubes were then incubated on ice for 15 minutes. 
The lysate was poured into the QIAfilter Cartridge (supplied in the kit) and incubated at 
room temperature for 10 minutes. At the same time, the HiSpeed Midi Tip (supplied in 
the kit) was equilibrated by 4ml of buffer QBT (supplied in the kit) and was allowed to 
empty by gravity flow. After the HiSpeed Midi Tip was equilibrated, the lysate was 
filtered into the Tip from the QIAfilter Cartridge by inserting a plunger. The cleared 





lysate was allowed to enter the resin by gravity flow. The resin was then washed by 2x 
10ml buffer QC (supplied in the kit) which was allowed to move through by gravity flow. 
After the washing, the DNA was eluted from the HiSpeed Midi Tip by using 5ml buffer 
QF (supplied in the kit). DNA was precipitated by adding 3.5ml isopropanol into the 
eluted DNA and incubated at room temperature for 5 minutes. The precipitated DNA was 
then transferred into a sterilized 20ml syringe and filtered through the QIAprecipitator 
(supplied in the kit) using constant pressure. Then the DNA in the QIAprecipitator was 
washed by 2ml of 70% ethanol. Finally the DNA was eluted from the QIAprecipitator by 
1.5ml sterilized water and sent to sequence. The concentration and purity of the extracted 
plasmid were evaluated by spectrophotometric absorbance readings at 260nm (Eppendorf 
Biophotometer, USA). The plasmid with Diva ORF correctly inserted was named as 
pcDNA6A-Diva and the plasmid with NDPK B ORF correctly inserted was named as 
pcDNA6A-NDPK B. 
2.7.4 PCR amplification 
In a sterile thin walled PCR tube, 2.5μl Mg2+ free 10x buffer, 1.5μl Mg2+ buffer, 
0.25μl Taq polymerase (Promega, USA), 0.5μl 10mM dNTP, 1μl 5mM forward primer, 
1μl 5mM reverse primer, 1μl cDNA template, and 17.25μl H2O were added in order and 
mixed well. The contents were then subjected to heating at 94°C for 2 minutes to 
denature, before 45 amplification cycles conditions of 94°C for 30 seconds, 60°C for 30 
seconds, 72°C for 1 minute; and a final extension at 72°C for 5 minutes.  
 
 





2.7.5 Agarose Gel Electrophoresis 
The specificity and size of the PCR product were examined by electrophoresis 
running on 1% agarose gel. Briefly, 0.5g of agarose powder was added to 50 ml of TAE 
buffer (40 mM Tris acetate, 1 mM EDTA, pH 8.0) in a conical flask, before heating in a 
microwave oven. The contents were then cooled under running water, before 1 µl of 
ethidium bromide was added. The solution was poured into the gel tank and the combs 
were inserted. The gel was then left for 30 minutes to solidify. The PCR products were 
then diluted 10 times before 5 µl was transferred to a new vial. The diluted product was 
mixed with 1 µl of DNA loading dye (Blue/Orange 6x loading dye-15% Ficoll, 0.03% 
bromophenol blue, 0.03% xylene cyanol FF, 0.4% orange G, 10 mM Tris-Hcl pH 7.5, 1 
mM EDTA, pH 8.0) before loading into the wells. A molecular weight marker (Promega) 
allowed the size of the amplicon to be determined. The gel was then run at 100V for 50 
minutes, and the bands were visualized under UV illumination with Gel Documentation 
Image Analysis System (Chemigenious SynGene, Cambridge, UK). 
2.7.6 Transfection of cells  
1x10
6 
cells were seeded into a six well plate and incubated at 37°C and 5% CO2 
for 24 hours. 4µl of Lipofectamine 2000; 2µg of pcDNA6A, pcDNA6A-Diva and 
pcDNA6A-NDPK B plasmids were diluted in 250µl of OPTI-MEM for 5 minutes 
respectively. The diluted Lipofectamine 2000 reagent was then added to the diluted 
plasmids, and the mixture was incubated at room temperature for 25 minutes. The cells 
were washed with 1xPBS twice, before 2ml of OPTI-MEM was added to the control 
group, and 1.5ml of OPTI-MEM was added to the remaining wells. The cells were then 





incubated for 5 hours at 37°C and 5% CO2. Thereafter, they were rinsed with 1xPBS 
once, before fresh media was added. 
2.8 MTS assay 
 In order to study if the NGF treatment had decreased the proliferation rate of the 
cells, cell numbers were assayed using CellTiter 96® Aqueous Non-Radioactive Cell 
Proliferation Assay (Promega), a colorimetric based technique that exploits the ability of 
viable cells to convert tetrazolium salt into formazan. In brief, cells were plated at a fixed 
number in 100 µl of cell medium into a 96-well plate and allowed to equilibrate for 2 
hours. Thereafter, 100 µl of PMS solution was added to 2 ml of MTS solution, and 20 µl 
of the PMS/MTS solution was added to each well. The plate was then incubated for 2.5 
hours in an incubator at 37°C and 5% CO2.  The absorbance for the plate was then read at 
490nm in the GENios plate reader. 
2.9 Brd-U (5-bromo-2´-deoxy-uridine) staining 
Brd-U staining was employed to study if the overexpression of Diva and NDPK B 
would affect proliferation rate, which is one of the key indicators of differentiation. 
The cells were transfected as mentioned above, before they were reseeded at 50% 
confluency. The number of proliferating cells was visualised and counted using the 5-
Bromo-2´-deoxy-uridine Labeling and Detection Kit I by Roche. In brief, the cell culture 
medium was aspirated and the cells were incubated with BrdU labelling medium for 30 
minutes at 37°C and 5% CO2. The labelling medium was then aspirated and the cells 
washed three times with the washing buffer provided. The cells were fixed in ethanol for 





half an hour at -20°C, washed and then incubated with the Anti-BrdU (1:100) working 
solution for 30 minutes at 37°C. After washing, Anti-mouse-Ig-fluorescein (1:200) 
working solution was added to the cells and incubated for 30 min at 37°C. After a final 3 
washes, the coverslips were mounted onto glass slides with Vectashield Mounting 
Medium with DAPI (Vector Labs, USA) and photos were taken using the confocal 
microscope (Fluoview1000, Olympus, Japan). 
2.10 Flow cytometry 
Propidium Iodide mixture:  
1xPBS 
0.1% triton X-100  
0.2mg/ml RNase A 
20ug/ml PI 
The cells were serum starved for 24 hrs so that they would be synchronised. 10% 
FBS was then added to the medium so that the cells could enter the cell cycle. At the 
designated time point, the cells were washed with 1xPBS, trypsinized and spun down at 
1500 rpm, 4ºC for 5 minutes. The cell pellet was then resuspended in 70% ethanol and 
left on ice for a minimum of 2 hours, or incubated at 4ºC overnight so as to fix the cells. 
Before flow cytometry analysis, the ethanol was removed, and the cells washed with 
1xPBS once. 1ml of the propidium iodide mixture was then added to the cells, and 
incubated at 37°C for 15 minutes. FACS analysis was carried out immediately and the 
results were analyzed using Summit software. 





2.11 Alizarin Red S Stain Analysis 
The media was aspirated from the 12 well plates and the MSCs were washed with 
1x PBS thrice. The cells were then fixed with 4% PF for 30 minutes before rinsing with 
1xPBS twice. The cells were stained with 2% Alizarin Red S solution for 2 minutes and 
rinsed thrice with distilled water.  
2.12 Alcian Blue Stain analysis 
The media was aspirated from the 12 well plates and the MSCs were washed with 
1x PBS thrice. The cells were then fixed with 4% PF for 30 minutes before rinsing with 
1xPBS twice. The cells were then stained with 1% Alcian Blue solution prepared in 0.1N 
HCL for 30 minutes. The wells were then rinsed thrice with 0.1N Hcl, and distilled water 
was added to neutralize the acidity. Blue staining indicates synthesis of proteoglycans by 
the chrondrocytes. 
2.13 Counting of differentiated cells and average neurite length 
The cells were counted as differentiated if the neurite length is more than twice 
of the length of the cell body. The average neurite length was measured using Image J 
software, and an average of 200 cells were counted for each set of experiment. 
2.14 Data analyses 
 All the experiments were repeated at least in triplicate for statistical purpose, and 
where appropriate, the data were presented as mean and standard deviation (SD). When 
comparing only two groups, the quantitative data was statistically evaluated using the 





Student‘s t-test. When comparison was made between groups, one-way ANOVA was 

























3.1 Changes in morphology and proliferation rates of PC-12 and NSC-34 cells 
after differentiation 
After application of 50ng/ml NGF and under reduced serum conditions of 1% FBS, 
the PC-12 cells changed from a rounded shape into neurite bearing cells (Fig 3.1A, 
top panel). By 3 days after differentiation, most of the PC12 cells had already borne 
processes.  
 
Figure 3.1 Changes in cell morphologies and proliferation rates of PC-12 and NSC-
34 cells after differentiation  
(A) Differentiation of PC-12 and NSC-34 cells led to outgrowth of neurites. 2 hours 
after plating, the cells were rounded in appearance. After treatment to induce 
differentiation, both PC-12 and NSC-34 cells started to differentiate and their 
processes began to elongate. The numbers of control and differentiated PC-12 and 
NSC-34 cells were quantified at 2 hrs after plating (0hr), 48hr, 96hr and 7 days. (B) 
After induction of differentiation, the number of PC-12 cells was significantly lesser 
than the control at all time points. (C) Differentiated NSC-34 cells also had a 
decreased proliferation rate as compared to control, but there was cell death at 7 








 The neurites were long and thin, and were about 1-2 times the length of the PC-12 
cell body. Most cells had only 2-3 neurites extending outwards. At 5 days after 
differentiation, the neurites were longer, extending more than 2 times the cell body 
length. The neurites also had a branched appearance. Similarly, NSC-34 cells also 
exhibited neurite outgrowth after induction of differentiation with DMEM F12 
medium and 1% FBS treatment. However, the neurites of the NSC-34 cells had fewer 
branches than the PC-12 cells, and although the neurites were longer, the cells 
appeared to be less healthy. 
 Both PC-12 and NSC-34 cells in the culture proliferated at a slower rate after 
inducing differentiation (Fig 3.1B & C). An exponential increase in cell number was 
observed in the undifferentiated PC-12 cells at 48 hours, but cell growth slowed and 
began to plateau thereafter. In contrast, the cells that were induced to differentiate did 
not have a peak in cell numbers but increased slowly and steadily up till 7 days (Fig 
3.1B).  The number of undifferentiated NSC-34 cells increased steadily over the 7 
days. In comparison, after induction of differentiation, the increase in cell number 
from 0 to 48 hrs was significantly lesser than control. However, the NSC-34 cells 
showed a decrease in cell number from 96 hr to 7 days after differentiation, indicating 
cell death (Fig 3.1C). 
 
3.2 Diva and NDPK B are reciprocally regulated during differentiation  
Both Diva and NDPK B can be found endogenously in NSC-34 and PC-12 cell 
lines (Fig 3.2). After the NSC-34 cells were differentiated for 2 days, the mRNA 






decreased to near basal levels by the 4
th
 day. β-tubulin showed a similar trend. 
However, Diva was consistently downregulated, up till 4 days after differentiation 
(Fig 3.2A). Comparatively, PC-12 showed a steady and significant increase in NDPK 
B levels, with a concurrent decrease in Diva expression levels during the course of 4 
days of differentiation. β-tubulin was only significantly upregulated after 4 days of 
differentiation (Fig 3.2B). 
 
Figure 3.2 mRNA expression of Diva and NDPK B in PC-12 and NSC-34 cells 
during differentiation 
Using RT-PCR, mRNA expression levels of NDPK B, Diva and β-tubulin were 
examined up till 4 days after induction of differentiation. (A) In NSC-34 cells, NDPK 
B and β-tubulin expressions were only significantly upregulated at 2 days after 
induction. Diva expression was downregulated at 2 and 4 days after induction. (B) In 
PC-12 cells, significantly at 2 and 4 days after differentiation, NDPK B expression 
was increased but expression of Diva was decreased. There was a marked increase in 
β-tubulin expression only at 4 days after differentiation. The quantitative analyses 
were done by normalising the values to actin in NSC-34 cells and GAPDH in PC-12 
cells. (*p<0.05) 
 
The expression levels of these proteins were also similar. β-tubulin expression 






differentiation was not significantly higher than the control, and there was a higher 
expression at 5 days of differentiation. In addition, β-tubulin co-localises with 
NDPK B, as seen by the more intense yellow staining in the merged field of Figure 
3.3 A. It is mainly expressed in the cytoplasm, although there was also strong 
immunoreactivity in the neurites (white arrow).  
In the normal cells, the distribution of Diva was detected to be in the cytoplasm, 
and NDPK B was mostly in the cytoplasm with some cells staining positive for the 
nucleus as well. By 3 days after differentiation, the cells expressed a lesser amount 
of Diva and this low expression was maintained at 5 days after differentiation (Fig 
3.3B). In contrast, differentiated cells stained more intensely for NDPK after 3 days 
of differentiation and remain elevated even at 5 days (Fig 3.3B). Graphical analysis 
showed that differentiated cells had a greater percentage of cells staining positive for 
NDPK B in the nucleus as compared to the control (Fig 3.3C). The same reciprocal 
expression pattern between Diva and NDPK B was observed in the NSC-34 cells 
(Fig 3.3D). After 3 days of differentiation, the expression of NDPK B was 
upregulated, whereas the expression of Diva was downregulated. At 5 days after 
differentiation, the expression of NDPK B remained similarly high but Diva 

















Figure 3.3 Protein Expression of Diva and NDPK B in PC-12 and NSC-34 cells 
during differentiation 
The cells were undifferentiated (control) or differentiated for 3 and 5 days. 
Thereafter, the PC-12 cells were fixed and double immunofluorescent stained. (A) β-
tubulin (green) with NDPK B (red) protein expressions were increased after 
differentiation. (B) Protein expression of Diva (green) expression was decreased after 
differentiation but NDPK B (red) expression was elevated. (C) Nuclear staining of 
NDPK B was observed in differentiated cells, and the percentage of cells with NDPK 
B in the nucleus was quantified by counting an average of 300 cells per group. There 
was a significant increase in cells with NDPK B in the nucleus after differentiation. 
(D) Protein from NSC-34 cells was extracted and immunoblotted. Western blot 
analyses comparing the expression profile of NDPK B and Diva in NSC-34 cells. (E) 
Bar chart showing the relative densitometric analysis of the expression levels of the 
different proteins. After differentiation, NDPK B expression was significantly 
upregulated with a reciprocal downregulation of Diva expression. 20µg of protein 










Although the NSC-34 and PC-12 showed similar trends in Diva and NDPK B 
protein expressions, downstream work was continued only with PC-12 cells because 
during the course of differentiation, the NSC-34 cells did not appear too healthy. For 
example, immunofluorescence was not performed with NSC-34 cells because a large 
proportional of cells detached from the surface during the numerous washing steps in 
the protocol.  
3.3 Endogenous Diva, NDPK B and β-tubulin form complexes with one 
another 
Using immunoprecipitation, results showed interaction between endogenous Diva 
and NDPK B, Diva and β-tubulin as well as β-tubulin and NDPK B (Fig 3.4). The 
amount of Diva/NDPK B and Diva/β-tubulin complexes decreased after 
differentiation but this was due to a decrease in the overall expression of Diva (Fig 
3.4A). Co-immunoprecipitation with β-tubulin antibody and immunoblotting for Diva 
confirmed this.  In contrast, the amount of NDPK B/β-tubulin complexes formed is 















Figure 3.4 Endogenous Diva, NDPK B and β-tubulin interact with one another. 
The cells were differentiated for 3 days before collection of cell lysate. The cell lysate 
was immunoprecipitated (IP) with Diva antibody (A) and β-tubulin antibody (B), 
before immunoblotting (IB) with the different antibodies. (A) The amount of Diva 
decreases after differentiation. The amount of Diva/NDPK B and Diva/β-tubulin 
complexes decreases after differentiation. (B) The amount of β-tubulin remains the 
same but the amount of NDPK/ β-tubulin complexes increases after differentiation. 
 
 Using the Duolink kit, the localization of the complexes could be identified. Diva, 
NDPK B and β-tubulin interacted predominantly in the cytoplasm (Fig 3.5).  The 
number of Diva/NDPK B (Fig 3.5A) and Diva/β-tubulin (Fig 3.5B) complexes were 
significantly decreased after differentiation, whereas the number of NDPK B/β-































Figure 3.5 Proximity Ligation Asssay (Duolink)   
The cells were differentiated for 3 days before they were fixed and labelled using the 
Duolink kit. Each fluorescent dot represents a complex formed between the proteins. 
The number of cytoplasmic complexes formed between Diva/β-tubulin (A) and 
Diva/NDPK B (B) decreased after differentiation, while there were more NDPK B/β-
tubulin (C) complexes after differentiation. The average intensity per cell was 
calculated using Blobfinder software and an average of 200 cells per group was used 
for analysis. (Bar=20µm, **p<0.01) 
 
3.4 Microtubule polymerisation facilitated formation of NDPK B/β-tubulin 
complexes over Diva/NDPK B and Diva/β-tubulin complexes 
The cells were treated with taxol to stabilize the microtubules and thereby 
investigate if the Diva/ NDPK B/ β-tubulin complexes were involved in microtubule 
polymerisation. Treatment with 25ng/ml of the drug for 24hours would induce 
microtubule polymerization, which is likely to require phosphorylation of β-tubulin 
by NDPK B. After taxol treatment, control cells had fewer Diva/β-tubulin complexes. 
Differentiated cells had a further decrease in amount of Diva/β-tubulin complexes 
after taxol treatment (Fig 3.6A). There was an increased number of NDPK B/β-
tubulin complexes in the taxol treated group both before and after differentiation, 
when compared to the untreated group (Fig 3.6B). The amount of Diva/NDPK B 








Figure 3.6 Taxol treatment alters the amount of complexes formed between 
Diva,NDPK B and β-tubulin 
The control cells were treated with only 25ng/ml of taxol, whereas the differentiated 
cells were treated with a cocktail of 50 ng/ml NGF and 25ng/ml taxol for 48 hours. 
(A) There were fewer Diva/β-tubulin complexes when the cells were treated with 
taxol. (B) There were more NDPK B/β-tubulin complexes for the taxol treated group. 
(C) There were lesser Diva/NDPK B complexes after taxol treatment. 
 
3.5 Overexpression of Diva protein did not alter NDPK B or β-tubulin 
expressions 
In order to investigate if Diva was responsible for preventing the association 
between NDPK B and β-tubulin during differentiation, the Diva protein was 
overexpressed in PC-12 cells. The 558 bp coding sequence (CDS) region of Diva 
was successfully cloned into pcDNA6A expression vector (Fig 3.7A). Ectopic 
expression of the Diva protein was also achieved in PC-12 cells, demonstrating 






Diva were significantly increased by about 5 times of control levels, but NDPK B 
and β-tubulin levels were not significantly affected by the ectopic expression of Diva 
(Fig 3.7C-E). 
 
Figure 3.7 Transfection of pcDNA6A-Diva in PC-12 cells    
(A) An amplicon of 558 bp was detected after PCR amplification, representative of 
Diva coding region. (B) Anti-6xHis tag identified the expression of a Diva 
polyhistidine fusion protein. (C) Real-time PCR validation of Diva overexpression 
24hr post-transfection showed significant increase. mRNA expressions of NDPK B 
and β-tubulin were not significantly altered by overexpression of Diva.  (D) 
Immunoblotting with antibodies 24 hrs post-transfection. Overexpression of Diva did 
not significantly change the protein expressions of NDPK B and β-tubulin. Results 
shown are representative of three independent experiments. (E)  Statistical analyses of 









3.6 Overexpressed Diva decreased neurite outgrowth and prevented the 
translocation of NDPK B into the nucleus during differentiation  
Double immunofluorescent labelling showed that the expression of ectopic Diva 
was mainly confined to the cytoplasm. In the undifferentiated cells, overexpression of 
Diva led to some nuclear localization of NDPK B which was not a significant 
percentage, so the majority of the protein was still expressed in the cytoplasm (Fig 
3.8A). However, in the differentiated cells, NDPK B localization and cellular 
morphology was altered due to the ectopic expression of Diva. While the control cells 
that were differentiated had translocation to the nucleus, Diva-overexpressing cells 
had most of their nucleus unstained with the NDPK B antibody (Fig 3.8B). Analysis 
showed that the percentage of differentiated cells with NDPK B in their nucleus was 
lesser in Diva-overexpressing cells (Fig 3.8C), indicating that Diva might be 
sequestering NDPK B in the cytoplasm. In addition, as seen in Fig 3.8B, cells with 
strong expression of Diva had shorter neurites, whereas cells with downregulated 
Diva expression had long neurites with strong co-localization of Diva and NDPK B at 
the neurite terminal (white arrow). Therefore, the number of differentiated cells as 
well as the average length of the neurites was quantitated. A cell was counted as 
differentiated if it had neurites longer than twice its body length. Diva-overexpressing 
cells had 53.76±3.75% differentiated cells, which was significantly lesser than the 
64.86±3.39% in the control (Fig 3.8D).  Diva-overexpressing cells also had shorter 


















Figure 3.8 Overexpression of Diva decreases cell differentiation and neurite length 
48hrs post-transfection with either the empty vector (pcDNA6A) or Diva 
overexpressing (pcDNA6A-Diva) plasmid, the cells were fixed and stained with Diva 
(green) and NDPK B (red) antibodies. (A) Overexpression of Diva resulted in 
stronger immunostaining in the cytoplasm. There was no change in NDPK B 
expression. (B)  In the pcDNA6A-Diva cells, Diva expression remained strong even 
after differentiation. There was strong colocalization of both proteins in the cytoplasm 
and at the neurite. (C) Overexpression of Diva prevents translocation of NDPKB into 
the nucleus after differentiation. It also decreases the percentage of differentiated cells 
(D) and their average neurite length (E). An average of 150 cells per group was 
counted for graphical analyses. (Bar =20µm, *p<0.05, **p<0.01) 
 
3.7 Diva overexpression decreased the formation of NDPK B and β-tubulin 
complexes 
Overexpression of Diva protein resulted in more Diva/β-tubulin and Diva/NDPK B 
complexes formed in the cytoplasm (Fig 3.9A and 3.10A). After differentiation, the 








of the downregulation of Diva (Results section 1.2 and 1.3). However, 
overexpression of Diva was able to abolish the decrease, and the number of Diva/β-
tubulin and Diva/NDPK B complexes remained relatively high even after 
differentiation (Fig 3.9A and 3.10A). Immunoprecipitation with Diva antibodies and 
immunoblotting with β-tubulin confirmed that overexpression of Diva increased the 
number of Diva/β-tubulin and Diva/NDPK B complexes both before and after 
differentiation (Fig 3.9B and 3.10B). In contrast, overexpression of Diva resulted in 
fewer NDPK B/β-tubulin complexes, regardless of the differentiation status of the cell 
(Fig 3.11).  
Therefore, the results suggest that Diva overexpression decreases the number of 
NDPK B/β-tubulin complexes by binding with both NDPK B and β-tubulin, thereby 
preventing their interaction with each other.  This is likely to have an effect on neurite 
outgrowth since NDPK B/β-tubulin association is needed for microtubule 












Figure 3.9 Overexpression of Diva increases the number of Diva-β-tubulin complexes                 
(A) Duolink experiment, with each discrete fluorescent dot representing a complex 
formed between Diva and β-tubulin. Overexpression of Diva resulted in more Diva/β-
tubulin complexes in both control and differentiated cells, 48hrs post-transfection. (B) 
Graphical analysis of the results in (A) showed the increase in the number of Diva/β-
tubulin complexes in the pcDNA6A-Diva cells to be significant. The average 
intensity per cell was calculated using Blobfinder software. An average of 200 cells 
per group was counted. (C) Results were confirmed with immunoprecipitation (IP)  
with Diva antibody followed by immunoblotting (IB) with β-tubulin antibody.  











Figure 3.10 Overexpression of Diva increases the number of Diva-NDPK B 
complexes                 
(A) 48hrs post-transfection, there were more Diva/NDPK B complexes formed after 
Diva was overexpressed. (B) Graphical analysis of the results in (A) showed the 
increase in the number of Diva/NDPK B complexes in the pcDNA6A-Diva cells to be 
significant. The average intensity per cell was calculated using Blobfinder software. 
An average of 200 cells per group was counted. (C) Diva/ NDPK B complexes were 











Figure 3.11 Overexpression of Diva decreases the number of NDPK B-β tubulin 
complexes 
 (A)  48hrs post-transfection, there were fewer NDPK B/β tubulin complexes formed 
in Diva-overexpressing cells. B) Graphical analysis of the results in (A) showed the 
decrease in the number of NDPK B/β tubulin complexes in the pcDNA6A-Diva cells 
to be significant. The average intensity per cell was calculated using Blobfinder 
software. An average of 200 cells per group was counted.  (C) NDPK B/β tubulin 










3.8 Diva increases proliferation of cells 
 The cells were treated with either growth media or differentiation medium for 24 
hours before they were assayed with BrdU staining (Fig 3.12A). Diva-overexpressing 
cells had a significantly greater number of cells that were in S phase in the control group 
(Fig 3.12B). This suggests that Diva is able to directly increase the proliferation rate of 
cells. Treatment of cells with NGF halved the number of dividing pcDNA6A cells, as the 
cells exit the cell cycle to rest in G0. However, overexpression of Diva was able to 
increase the number of cycling cells (Fig 3.12B). Therefore it is likely that during the 
course of differentiation, downregulation of Diva is needed for the cells to exit the cell 
cycle to rest in G0. Using MTS assay, growth curves for pcDNA6A and pcDNA6A-Diva 
were plotted over a 4 day period (Fig 3.12C). As expected, Diva-overexpressing cells had 
significantly greater number of cells as compared to the control. However, by 4 days both 
pcDNA6A and pcDNA6A-Diva had similar cell numbers, as there was a decrease in 
pcDNA6A-Diva cells due to space constraints in the well. The NGF-treated cells had a 
slower proliferation rate as compared to the control cells. There was a significant increase 
in cell number of pcDNA6A-Diva cells as compared to pcDNA6A cells only 4 days after 







Figure 3.12 Diva positively regulates cellular proliferation.   
(A) The number of cells in S phase is visualised by BrdU staining (green) in the 
nucleus. (B) Overexpression of Diva resulted in a significant increase in number of S 
phase cells in both control and differentiated groups. An average of 150 cells was 
counted per group for analysis. (C) The growth curves of the cells were plotted using 
absorbance values from MTS assay. Diva overexpressing cells had a significantly 
higher peak at 2 days as compared to control. Under differentiating conditions, 
pcDNA6A-Diva cells had more cells only 4 days after culture. (Bar=20µm. *p<0.05) 
 
3.9 Diva promotes serum induced cell cycle entry and attenuates apoptotic cell 
death 
To determine the effect of Diva on cell cycle, cell cycle analysis using propidium 






the pcDNA6A and pcDNA6A-Diva plasmids were serum starved for 24 hours to arrest 
the cells in G0/G1 phase and induced to re-enter the cell cycle by serum addition. As seen 
in Fig 3.13A, after serum starvation, the peak at the G2/M phase disappears, indicating 
that the cells were successfully arrested. Following serum addition, the peak shift towards 
the right for pcDNA6A-Diva cells is faster as compared to the empty vector cells. A 
graphical plot using software analysis showed that Diva-overexpressing cells had 
significantly more S-phase cells as compared to the control cells at 6 hrs and 12 hrs (Fig 
3.13B). At 24 hrs, a portion of the pcDNA6A cells were still in S-phase, while nearly all 
the pcDNA6A-Diva cells had already entered the G2/M phase, indicating Diva-
overexpressing cells had faster serum induced cell cycle entry.   
The percentage of cells in sub G1 phase in flow cytometry analysis is commonly 
acknowledged to indicate apoptotic cells, due to the presence of fragmented DNA. 
Consistently at every time point throughout the 24 hours, pcDNA6A-Diva cells had 
significantly lesser apoptotic cells as compared to control (Fig 3.13C). This suggests that 







Figure 3.13 Diva accelerates serum-induced cell cycle entry and decreases apoptotic cell 
death. 
(A) PI/FACS profile of cells before serum starvation (10% FBS), after serum starvation 
for 24 hours (0hr), and at indicated times after serum addition. (B) Graph of percentages 
of S phase cells by Summit software analysis of data from (A) show an increase for the 
pcDNA6A-Diva cells. (C) Graph of percentages of apoptotic cells by Summit software 











3.10 Expression of cell cycle machinery components was altered in 
pcDNA6A-Diva cells 
To investigate the mechanism utilized by Diva for faster cell cycle entry, 
expression of the different cell cycle machinery components was profiled. There was 
significantly higher transcriptional expression of cyclin D1 in the pcDNA6A-Diva cells 
(Fig 3.14A). In contrast, expression of cyclin D3 was not affected (Fig 3.14B). mRNA 
expression of p15 in the Diva-overexpressing cells was similar to control at 0 and 8 hrs,  
but there was a sharp decrease at 12hrs before increasing again to near control levels at 
24 hrs (Fig 3.14C). Similarly, p27 levels were indistinguishable from control at 0 and 8 
hrs, and decreased significantly at 12 hrs. However, at 24 hrs the mRNA expression of 
p27 increased considerably and was higher than control (Fig 3.14D). There was also 







Figure 3.14 Diva overexpression alters the gene expression of cell cycle machinery. 
The pcDNA6A and pcDNA6A-Diva cells were serum starved for 24 hrs before serum 
was added to stimulate cell cycle entry. The time indicated represents the hours after 
serum addition, and 0hrs represent serum starved cells. (A) Cyclin D1 had increased 
expression at 8 and 12 hrs as compared to control. (B) Cyclin D3 had no significant 
change in mRNA levels. (C) p15 expression was downregulated at 12hrs but became 
indistinguishable from control by 24 hrs. (D) Compared to control, p27 expression 
was also significantly downregulated at 12 hrs. By 24 hrs, expression increased 
substantially and became higher than control. (E) mRNA expression of 
retinoblastoma (Rb) was significantly higher than control at 12 and 24hrs. (F) E2F-1 









The levels of CDKs in the cells are constant throughout the cell cycle, and it is the 
regulation of cyclins that is crucial in mediating cell cycle entry. As expected, serum 
starvation for 24 hours resulted in minimal protein expression of cyclin D1 and D3 (Fig 
3.15A), which is consistent with G0/G1 arrest. Cyclin D1 was induced by 8hrs in both 
pcDNA6A and pcDNA6A-Diva cells, and there was a significantly stronger expression 
in the Diva overexpressing cells at 12hrs compared to control. At 24 hours, there was 
similarly strong expression of cyclin D1 between the pcDNA6A and pcDNA-Diva cells. 
As seen in Fig 3.15B, the ectopic expression of Diva had no significant effect on cyclin 
D3, as protein levels of the pcDNA6A-Diva cells were consistent with the empty vector 
cells at the various time points. 
The expression of both CIP/KIP and INK4 families CDKIs was also investigated, 
since cyclin/CDK activities can be regulated by the binding of CDKIs. Following G0/G1 
arrest by serum starvation, there was high expression of both p15 and p27 (Fig 3.15 C & 
D). Expression of p15 decreases significantly from 8hrs to 12hrs, as the cells begin to 
enter S-phase. There was lower expression of p15 in the Diva-overexpressing cells at 12 
hrs as compared to control, but by 24 hrs the amount of protein became higher than the 
control (Fig 3.15C). A similar trend was also observed for p27 protein levels (Fig 
3.15D). The increase in CDKI expressions at 24hrs for the pcDNA6A-Diva cells is 














Figure 3.15 Diva overexpression alters the protein expression of cell cycle machinery. 
The pcDNA6A and pcDNA6A-Diva cells were serum starved for 24 hrs before serum 
was added to stimulate cell cycle entry. The time indicated represents the hours after 
serum addition, and 0hr represent serum starved cells. Lysates of the cells were then 
immunoblotted. As compared to control, Diva overexpressing cells had increased 
cyclin D1 at 8 and 12 hrs (A), no change for cyclin D3 (B), lesser p15 at 12 hrs (C) 
and lesser p27 at 12 hrs (D). There was also increased pRB at 12 and 24hrs (E) and 
increased E2F-1 at 12 and 24hrs (F). For each antibody and timepoint, the lysates 
were also immunoblotted for β-actin as a loading control but it is not shown for ease 
of representation. 
 
Next, the phosphorylation status of the RB protein, which is a substrate of the 
cyclin/CDK complex, was examined (Fig 3.14E). There is a steady increase in amount 
of pRB from negligible amounts at 0hrs till 12hrs, when there is a substantially higher 
expression in pcDNA6A-Diva cells. This elevated expression is continued even at 24hrs 
(Fig 3.14E). Hyperphosphorylated Rb would then release the E2F family of 
transcription factors, which would then transcribe genes, including itself, for progression 
of the cell cycle. Indeed, Fig 3.14F shows that E2F-1 expression escalates from 0hrs to 
24 hrs. For both control and Diva-overexpressing cells, expression of E2F-1 becomes 
detectable at 8 hrs. However, at 12hrs and 24hrs there is a marked increase in protein 
level in the pcDNA6A-Diva cells as compared to control. 
Hence, the data suggests that the overexpression of Diva leads to faster accumulation 
of cyclin D1 as well as faster degradation of p15 and p27. This would result in more 
active cyclin/CDK complexes that would enable the cells to be released from G1 arrest 
at a faster rate than the control. Therefore, this result is synchronous with the previous 






proportion of the cells in S-phase at the 12hr timepoint, a phenomenon likely caused by 
the faster entry into the cell cycle by Diva-overexpressing cells.  
3.11 Overexpression of NDPK B protein in PC-12 cells 
NDPK B was upregulated and translocated to the nucleus during PC-12 neuronal 
differentiation. Hence, in order to test if the upregulation of NDPK B expression was the 
cause or consequence of differentiation, NDPK B was also overexpressed in PC-12 cells. 
The 469 bp CDS region of NDPK B was also successfully cloned into pcDNA6A 
expression vector (Fig 3.16A). Ectopic expression of the NDPK B protein was also 
achieved in PC-12 cells, demonstrating successful transfection (Fig 3.16B).  The mRNA 
expression of NDPK B was increased by 8.37 times, whereas its protein expression levels 
had a 6 fold increase. β-tubulin was also significantly increased by about 2 fold. 
Overexpression of NDPK B led to attenuation in expression of Diva, to about 30% of the 







Figure 3.16 Transfection of pcDNA6A-NDPK B in PC-12 cells.      
(A) An amplicon of 469 bp was detected after PCR amplification, representative of 
NDPK B coding region. (B) Anti-6xHis tag to identify the expression of a NDPK B 
polyhistidine fusion protein. (C) Real-time PCR validation of NDPK B 
overexpression 24hr post-transfection. (D) Immunoblotting with antibodies 24 hrs 
post-transfection. Results shown are representative of three independent experiments. 
(E)  Statistical analyses of the western blot bands. The band densities are calculated 
relative to the control group, pcDNA6A. (*p<0.05, **p<0.01) 
 
3.12 Overexpressed NDPK B promotes differentiation and outgrowth of 
neurites 
The expression of NDPK B was significantly upregulated and it caused 
downregulation of Diva in the pcDNA6A-NDPK B cells despite being undifferentiated 






arrows). The NDPK B-overexpressing cells also had a more branched morphology, with 
greater outgrowth of neurites when exposed to NGF treatment (Fig 3.17B). Ectopic 
NDPK B was expressed in both nucleus and cytoplasm of the transfected cells, therefore 
leading to significant increases in the percentages of undifferentiated and differentiated 
cells with NDPK B in their nucleus (Fig 3.17C). NDPK B-overexpressing cells had 
82.4±2.81% differentiated cells, which was significantly more than the 64.86±3.39% in 
the control (Fig 3.17D).  NDPK B-overexpressing cells also had longer neurites, 
measuring 45.42.6 ± 1.54µm as compared to 28.74 ± 1.55 µm in control cells (Fig 
3.17E). Therefore, this shows that NDPK B upregulation during differentiation is to 





















Figure 3.17 Overexpression of NDPK B increases cell differentiation and neurite 
length  
48hrs post-transfection, the cells were immunostained with the different antibodies, 
Diva (green) and NDPK B (red) to visualize their subcellular localization. (A) 
Overexpressed NDPK B is located in the nucleus and cytoplasm (B) NDPK B-
overexpressing cells had a more branched morphology after differentiation. (C) The 
percentages of cells with NDPK B in the nucleus were greatly elevated after the 
protein was overexpressed. Both the percentage of differentiated cells (D) and 
average neurite length (E) of the differentiated cells were increased in the NDPK B 
overexpressing cells. (Bar=20µm, *p<0.05, **p<0.01, ***p<0.001) 
 
3.13 NDPK B overexpression increases number of NDPK B/β-tubulin 
complexes while decreasing Diva/NDPK B and Diva/β-tubulin complexes 
There were a greater number of NDPK B/ β-tubulin complexes in the NDPK B 
overexpressing cells, and their expression can be clearly seen to be along the neurite 
tract (white arrow) when exposed to NGF-treatment (Fig 3.18 A). Graphical analysis 



















Figure 3.18 Overexpression of NDPK increases the number of NDPK B/β-tubulin 
complexes                 
(A) Duolink experiment, with each discrete fluorescent dot representing a complex 
formed between NDPK B and β-tubulin. Overexpression of NDPK B resulted in more 
NDPK B/β-tubulin complexes in both control and differentiated cells, 48hrs post-
transfection. (B) Graphical analysis of the results in (A) showed the increase in the 
number of NDPK B/β-tubulin complexes in the pcDNA6A-NDPK B cells to be 
significant. The average intensity per cell was calculated using Blobfinder software. 








In contrast, there were fewer Diva/ NDPK B complexes in the pcDNA6A-NDPK B 
cells (Fig 3.19A). The change was significant only in the undifferentiated cells. After 
NGF-treatment, there were few complexes in both pcDNA6A and pcDNA6A-NDPK B 
cells (Fig 3.19B). 
 
 
Figure 3.19 Overexpression of NDPK decreases the number of Diva/NDPK B 
complexes                 
(A) Overexpression of NDPK B resulted in a lesser amount of Diva/NDPK B 
complexes in both control and differentiated cells, 48hrs post-transfection. (B) 
Graphical analysis of the results in (A) showed the decrease in the number of 
Diva/NDPK complexes in the pcDNA6A-NDPK B cells to be significant. The 
average intensity per cell was calculated using Blobfinder software. An average of 








Similarly, the amount of Diva/β-tubulin complexes decreased in the NDPK B 
overexpressing cells for the undifferentiated cells, but with no significant change in 
the differentiated cells (Fig 3.20). 
  
 
Figure 3.20 Overexpression of NDPK decreases the number of Diva/β-tubulin 
complexes                 
(A) Overexpression of NDPK B resulted in fewer Diva/β-tubulin complexes in both 
control and differentiated cells, 48hrs post-transfection. (B) Graphical analysis of the 
results in (A) showed the decrease in the number of Diva/β-tubulin complexes in the 
pcDNA6A-NDPK B cells to be significant. The average intensity per cell was 









3.14 NDPK inhibits cellular proliferation 
The cellular proliferation of NDPK overexpressing cells was investigated to elucidate 
if NDPK B expression regulated the process. The cells were treated with either growth 
media or differentiation medium for 24 hours before they were assayed with BrdU 
staining (Fig 3.21A). NDPK B-overexpressing cells in the control group had a 
significantly lesser number of cells that were in S phase (Fig 3.21B). This indicates that 
NDPK B overexpression could retard the proliferation rate of cells. In fact, the number of 
dividing cells in the untreated pcDNA6A-NDPK B group was similar to the NGF-treated 
control pcDNA6A group, suggesting that increased NDPK B expression is responsible 
for the decreased proliferation during differentiation in normal cells. Overexpression of 
NDPK was also able to further decrease the number of cycling cells in the NGF-treated 
group (Fig 3.21B). Using MTS assay, growth curves for pcDNA6A and pcDNA6A-
NDPK B were plotted over a 4 day period (Fig 3.21C). NDPK B-overexpressing cells 
had significantly fewer cells as compared to the control at 2 days after plating. However, 
by 4 days both pcDNA6A and pcDNA6A-NDPK B had similar cell numbers, as the 
growth of pcDNA6A cells plateaued due to space constraints in the well. The growth 
curve for NDPK B overexpressing cells was slightly slower than the control cells when 







Figure 3.21 NDPK B negatively regulates cellular proliferation.   
(A) The number of cells in S phase are visualised by BrdU staining (green) in the 
nucleus. (B) Overexpression of NDPK B decreased the number of S phase cells in 
both control and differentiated groups. An average of 150 cells was counted per group 
for analysis. (C) The growth curves of the cells were plotted using absorbance values 
from MTS assay. Overexpression of NDPK B significantly slowed the growth of 


















3.15 NDPK B retards serum induced cell cycle entry  
To determine the effect of NDPK B on cell cycle, cell cycle analysis using 
propidium iodide staining and flow cytometry was performed (Fig 3.22A). PC-12 cells 
containing the pcDNA6A and pcDNA6A-NDPK B were serum starved for 24 hours to 
arrest the cells in G0/G1 phase and induced to re-enter the cell cycle by serum addition. 
Following serum addition, the peak shift towards the right for pcDNA6A-NDPK B cells 
is slower as compared to the empty vector cells. A graphical plot using software analysis 
showed that control cells exited G1-phase to enter into S-phase cells by 12 hrs, whereas 
the NDPK-B overexpressing cells had a delay in G1 and only had a substantial S phase 
population by 24 hrs (Fig 3.22B & C). This indicates that NDPK B could retard serum-
induced cell cycle entry by causing G1-phase arrest. The percentage of apoptotic cells 
was not significantly different between the control and NDPK B overexpressing cells so 








Figure 3.22 NDPK B retards serum-induced cell cycle entry 
(A) PI/FACS profile of cells before serum starvation (10% FBS), after serum 
starvation for 24 hours (0hr), and at indicated times after serum addition. (B) Graph 
of percentages of G1-phase cells showed increased numbers of G1-phase cells from 0 
to 12 hrs after serum readdition for the NDPK B overexpressing cells. (C) The 
percentage of S phase cells was significantly downregulated by NDPK B 
overexpression, from 6 till 12hrs. Graphs were generated by Summit software 







3.16 Expression of cell cycle machinery components was altered in 
pcDNA6A-NDPK B cells 
To determine if NDPK B was regulating the cell cycle in the same manner as Diva, 
the expression profile of the various cell cycle proteins was analysed. When compared 
against the cells with empty vector, Cyclin D1 mRNA expression was significantly 
downregulated in the NDPK B overexpressing cells from 8 till 24 hrs (Fig 3.23A). 
Expression of cyclin D3 was also downregulated, but only at 12 and 24 hrs (Fig 3.23B). 
The expression of CDKIs, p15 (Fig 3.23C) and p27 (Fig 3.23D) were both elevated at 8 
and 24 hrs, although only p15 showed significant increase at 12hrs. The transcriptional 
expressions of both RB (Fig 3.23E) and E2F-1 (Fig 3.23F) in the pcDNA6A-NDPK B 









Figure 3.23 NDPK-B overexpression alters the gene expression of cell cycle 
machinery. 
The pcDNA6A and pcDNA6A-NDPK B cells were serum starved for 24 hrs before 
serum was added to stimulate cell cycle entry. The time indicated represents the hours 
after serum addition, and 0hrs represent serum starved cells. (A) mRNA expression of 
Cyclin D1 in the NDPK B overexpressing cells was significantly downregulated from 
8hrs till 24 hrs as compared to control. (B) Cyclin D3 expression was also 
downregulated at 12 and 24 hrs. (C) p15 expression was upregulated from 8 till 24 hrs 
as compared to control. (D)  p27 expression was higher than control at 8 and 24hrs. 
(E & F) RB and E2F-1 expressions were significantly lesser than control from 8hrs 









As seen in Fig 3.24A, expression of cyclin D1 in the pcDNA6A-NDPK B cells is 
comparable to the control from 0hrs to 12 hrs, and was only significantly lower at 24hrs. 
Contrary to the results for Diva, NDPK B also affected cyclin D3 expression (Fig 3.24B). 
While cyclin D3 protein levels surged at 12 hrs in the control cells, an increase in 
expression was only detected at 24hrs for the NDPK B overexpressing cells. 
In the control cells, the expression of p15 and p27 are highest in arrested cells and 
gradually decreases (Fig 3.24C & D). There was a major dip in p15 protein level at 12hrs 
in the control cells, but this decrease was delayed in the pcDNA6A-NDPK B cells and 
was only apparent at 24hrs (Fig 3.24C). As for p27, expression remained high in the 
NDPK B overexpressing cells even at 24 hrs (Fig 3.24D). 
In comparison to the control cells, pRB levels in the pcDNA6A-NDPK B were 
attenuated at 8hrs and 12hrs, but became similar as control at 24hrs (Fig 3.24E). A 
distinct band was observed for its substrate, E2F-1 in the pcDNA6A cells at 12 hrs. In 
contrast, a discernable band for the pcDNA6A-NDPK B cells had a time lag and was 
















Figure 3.24 NDPK-B overexpression alters the protein expression of cell cycle 
machinery. 
The pcDNA6A and pcDNA6A-NDPK B cells were serum starved for 24 hrs before 
serum was added to stimulate cell cycle entry. The time indicated represents the hours 
after serum addition, and 0hrs represent serum starved cells. Lysates of the cells were 
then immunoblotted. There was decreased cyclin D1 (A), and cyclin D3 (B) in the 
pcDNA6A-NDPK B cells as compared to control. (C) Protein expression of p15 was 
higher at 12hrs as compared to control. (D) p27 had an elevated expression at 12 and 
24hrs. (E) pRB protein levels were lower than control from 8 to 24hrs. (F) E2F-1 
expression was decreased at 12 and 24hrs in the NDPK B overexpressing cells. For 
each antibody and time point, the lysates were also immunoblotted for β-actin as a 
loading control but it is not shown for ease of representation. 
 
3.17 Characterization of primary mesenchymal stem cells (MSCs)  
The usual protocol for isolation of mesenchymal stem cells has been based on their 
exclusive ability to form adherent cell layers in culture. Nonetheless, the resulting 
population is heterogeneous. Hence, the isolated MSCs were characterized with a panel 
of positive and negative selection markers, as there is no fixed MSC-specific marker. As 
seen in Fig 3.25A, MSCs did not have any staining for CD14 and CD 45. These two 
molecules are specific hematopoietic cell surface markers, with CD14 being present on 
leukocytes and CD45 present on monocytes and macrophages. The MSCs also stained 
positively for cell surface molecules, integrin β1 and CD54, as well as extracellular 
matrix proteins, fibronectin and type I collagen. 
In addition, the isolated MSCs were also tested for their multi-potentiality. The 
cells were differentiated into osteogenic and chondrocytic lineages and stained positive 
for Alizarin Red and Alcian Blue respectively. 
Thus, the cells that were isolated and purified were ascertained to fulfil the criteria 







Fig 3.25 Characterization of isolated MSCs 
(A) Isolated cells were stained with a selection of positive and negative markers to 
ascertain their identity. (B) MSCs were differentiated for 21 days into osteoclasts and 
stained with Alizarin red. (C) MSCs were differentiated for 14 days and the developing 
chrondrogenic pellet was stained with Alcian Blue. (White bar=50µm, Black 
bar=100µm) 
  
3.18 Overexpression of NDPK B and Diva in MSCs 
To observe if adding Divain the MSCs could affect MSCs‘ differentiation, the 
MSCs were transfected with pcDNA6A, pcDNA6A-Diva and pcDNA6A-NDPK B 
plasmids. As seen in Fig 3.26A, there was a low basal level expression of both NDPK B 












increase in NDPK B expression in both the nucleus and cytoplasm of the cells, but 
expression was predominantly in the cytoplasm, with  approximately 40% of the cells 
having diffused staining in the nucleus (Fig 3.26D). There were no discernable effects of 
NDPK B overexpression on Diva protein level (Fig 3.26B). This could be because of the 
low amounts of Diva in MSCs. While pcDNA6A-Diva MSCs also only showed more 
intense Diva staining in the cytoplasm (Fig 3.26C), remarkably it also led to an 
upregulation in NDPK B protein level, with nuclear expression of NDPK B in cells with 
altered morphology (Fig 3.26B, white arrows). Interestingly, in cells transfected with the 
NDPK B and Diva plasmids, a greater number of cells with altered morphology were 
observed. The morphology of these cells became more rounded with process outgrowth, 
and appeared to have a differentiated phenoptype (white arrows). Fig 3.26E shows that 
the percentage of cells with differentiated phenotype is significantly higher in 
pcDNA6A-Diva and pcDNA6A-NDPK B cells.  In fact, the rounded cells had increased 
appeared to have more colocalization of both proteins, seen as a more intense yellow 
staining. However, this could be because the cell body is spread over a smaller area, thus 







Figure 3.26 Overexpression of NDPK B and Diva in MSCs 
(A-C) The MSCs were transfected with pcDNA6A (A), pcDNA6A-NDPK B (B) and 
pcDNA6A-Diva (C) plasmids before they were fixed and double-labeled with the 
Diva (green) and NDPK B (red) antibodies, and counterstained with DAPI (blue). 






in the nucleus (D). Cells that overexpressed either Diva or NDPK B had higher 
percentages of differentiated cells (E). An average of 150 cells per group was 
calculated for statistical analyses. (Bar=20µm. *p<0.05, **p<0.01)  
 
3.19 The cells with a differentiated phenotype are oligodendrocyte-like 
cells 
MSCs are multipotent cells with the ability to transdifferentiate into different 
neural lineages such as neurons, oligodendrocytes and astrocytes (Portmann-Lanz 
et al., 2010). Hence to determine the nature of these cells with a differentiated 
morphology, the cells were stained with the various cell markers after transfection. 
The cells did not show any staining for Notch-1 or neuron specific enolase (data 
not shown), but stained positive for CNPase, a marker for oligodendrocytes (Fig 
3.27).  
 
Figure 3.27 Cells that overexpress NDPK B and Diva differentiate into 
oligodendrocyte-like cells 
The cells were transiently transfected with the different plasmids before they were 
fixed 24hrs later and stained with different markers for neural lineages. The cells 









3.20 Ectopic expression of Diva and NDPK B alters the proliferation rates 
of MSCs 
After overexpressing the proteins in MSCs, the proliferating cells were stained with 
FITC tagged anti-BrdU antibody (Fig 3.28A). Similar to the result in PC-12 cells, MSCs 
that overexpressed Diva had an increased proliferation rate, while MSCs that 
overexpressed NDPK B had significantly fewer S-phase cells than the control (Fig 
3.28B).  
 
Figure 3.28 Diva and NDPK B overexpression alters the percentage of BrdU positive 
cells. 
The cells were transiently transfected with the different plasmids before they were fixed 
24hrs later. (A) Cells that were in S-phase had their nuclei labelled with BrdU antibody 
(green) and counterstained with DAPI (blue). (B) pcDNA6A-Diva cells had a significant 






positive cells as compared to control. An average of 300 cells were counted for each 
group and analysed statistically. (Bar=20µm. *p<0.05, **p<0.01) 
3.21 Overexpression of Diva and NDPK B altered the cell cycle 
The MSCs were first subjected to 24hrs of serum starvation to synchronize the cells 
in G1 phase, before they were fixed and stained with PI. Fig 3.29A shows the FACS 
profiles of the cells. After cell cycle arrest (0hr), compared to the control, NDPK B 
overexpressing cells had a greater percentage of apoptotic cells, and it remains 
significantly higher until 12 hrs post serum addition. However, within that same time 
frame, there was lesser apoptosis in the Diva overexpressing cells (Fig 3.29B). At 6hrs 
and 12 hrs post serum addition, the percentage of apoptotic cells in pcDNA6A and 
pcDNA6A-NDPK B escalates, while the percentage of apoptotic cells in pcDNA6A-
Diva remains constantly low. The observed cell death is likely an after effect of serum 
starvation since at 24 hrs, the percentage of apoptotic cells in control and NDPK B 
overexpressing cells drops to nearly the same level as pcDNA6A-Diva cells (Fig 
3.29C). At 6 hrs after serum stimulation, both pcDNA6A and pcDNA6A-Diva cells 
began to exit G1 and enter S-phase, as seen by the significant decrease in G1-phase cells 
(Fig 3.29C) and peak in S-phase cells (Fig 3.29D). Diva overexpressing cells had 
significantly more S-phase cells than the control. Even at 12 hrs, levels remain high and 
it is only at 24 hrs that there is a hike in cells at G2/M phase (Fig 3.29E). In contrast, at 
6 and 12 hrs, NDPK B overexpressing cells continued to be arrested in G1-phase (Fig 










Figure 3.29 Overexpression of Diva and NDPK B in MSCs alters the cell cycle 
The MSCs were serum starved for 24 hours before serum was added. (A) PI/FACS 
profiles of the cells. (B) Graph of percentages of apoptotic cells showed a significant 






Diva overexpressing cells. Up till 12 hrs, pcDNA6A-NDPK B had majority of its cells 
in G1 phase (C), whereas the pcDNA6A and pcDNA6A-Diva cells had a considerable S 
phase (D) population by 12 hrs. By 24 hrs, all three groups were in G2/M phase (E), 
although the NDPK B overexpressing cells still had a significantly lower percentage. 
Graphical analysis by Summit software analysis of data obtained from (A). (*p<0.05, 
**p<0.01) 
 
3.22 Cell cycle altered due to changes in p27 and cyclin D expression levels 
To determine if Diva and NDPK could also regulate the MSC cell cycle via p27 
and cyclin D, as in PC-12 cells, the MSCs were starved from serum before collecting 
total cell lysates at fixed time points after serum addition and performing western 
blotting. As seen in Fig 3.30A, serum starvation caused increased expression of p27, 
which decreased temporally after serum was added. At 6 hr, p27 expression remained 
elevated only in control and pcDNA6A-NDPK B cells, with pcDNA6A-Diva showing a 
less intense band. By 24 hrs, only pcDNA6A-NDPK B cells retained a prominent band 
on the western blot.  
The reverse trend was observed for cyclin D1, with low levels detected directly 
after serum starvation and protein amounts increasing with time after serum addition 
(Fig 3.30B). By 6 hr, both pcDNA6A and pcDNA6A-Diva had an upregulation in cyclin 
D1 protein expression, and it was only at 12 hrs that a stronger expression was detected 
in Diva-overexpressing cells as compared to control. By 24 hrs, as the cells have 
progressed through the checkpoint, the expression of the protein in pcDNA6A and 
pcDNA6A-Diva was detected to be minimal again. In contrast, as the NDPK B cells 
have a lag in cell cycle entry, the surge in cyclin D1 expression was only observed at 12 







Figure 3.30 p27 and Cyclin D1 protein levels of transfected MSCs. 
The pcDNA6A-Diva cells entered the cell cycle more quickly than pcDNA6A cells 
because of a faster decrease in p27 levels (A) and a higher expression of cyclin D1 (B). 
In the same manner, pcDNA6A-NDPK B had retarded cell cycle entry because of 
elevated p27 levels and delayed expression of cyclin D1. 
 
3.23 Diva increases interaction with NDPK B and β-tubulin in MSCs with 
differentiated phenotype 
To investigate if the change in morphology of the MSCs could also require altered 
interactions between Diva, NDPK B and β-tubulin, the Duolink assay was used to 
investigate the flux of the molecular complexes. As seen in the left panel of Fig 3.31, 
there was very little interaction between the endogenous proteins in the control cells, 






cells, there was strong staining observed only in cells with a differentiated phenotype 
(white arrows). The staining was predominantly in the cytoplasm of the cell body, 
indicating increased numbers of Diva/NDPK B, Diva/β-tubulin and NDPK B/β-tubulin 
complexes. Thus the overexpression of NDPK B protein increasesd expression of Diva 
selectively in cells with a differentiated morphology, and this also led to increased 
association between the proteins. In contrast, while the overexpression of Diva caused a 
surge in NDPK B expression in most transfected cells, the strong association between 
the proteins was observed mainly only in differentiated cells. This indicates that the 
complexes may be discriminatory in their association, and not solely due to expression 
levels. Nonetheless, in pcDNA6A-Diva and pcDNA-NDPK B cells there was also a 
slight increase in complexes, especially for NDPK/β-tubulin, for cells that were without 
the differentiated phenotype. Interestingly, complexes were also found in the nucleus. 
Hence, other than for changes in morphological shape, these complexes might have 










Figure 3.31 Increased number of complexes formed between Diva, NDPK B and 
β-tubulin in differentiated cells 
The cells were transiently transfected with the different plasmids before they 
were fixed and assayed with the Duolink kit to study the interactions of the 
different proteins. In the cells overexpressing either Diva or NDPK B, cells with 
a differentiated morphology had increased Diva/β-tubulin, Diva/ NDPK B and 





































 The Bcl-2 family is well known for its functional roles in apoptosis, but in 
recent years there has been increasing reports for a role in differentiation for these 
proteins (Liang et al., 2003). The hypothesis of this study was that Diva was also 
involved in differentiation, as previous studies had shown that the expression pattern 
of Diva changes during the course of development. Diva is strongly expressed in the 
brain, liver, and heart of E15 embryonic mice but becomes restricted to the granulosa 
cells of the ovary and the seminiferous tubules of the testis in adult mice (Inohara et 
al., 1998; Song et al., 1999). In this study, PC-12 and NSC-34 cell lines were used to 
study the role of Diva in differentiation, because they have been commonly used as 
models of neuronal differentiation (Cashman et al., 1992; Suzuki et al., 1998), and 
have endogenous expression of Diva. 
 The results in this study propose a novel function for Diva, a member of the 
Bcl-2 family, by demonstrating that the protein may be involved in the negative 
regulation of neuronal differentiation. Diva inhibited neurite outgrowth in PC-12 cells 
by decreasing the amount of NDPK B/β-tubulin complexes as Diva formed more 
complexes with NDPK B and β-tubulin respectively. Diva also positively regulated 
cell proliferation. Diva prevented the translocation of NDPK B into the nucleus 
during differentiation, which led to increased expressions of cyclins, pRB and E2F-1 
as well as decreased expressions of p27 and p15. Interestingly, transfection of Diva 
and NDPK B plasmids individually into primary MSCs resulted in the appearance of 
cells with a differentiated phenotype. Immunostaining staining with neural markers 
showed the cells to be oligodendrocyte-like cells, and there was a large amount of 







4.1 Diva expression decreased during differentiation and overexpression of 
the protein prevented the nuclear translocation of NDPK B 
Thus far, reports on Diva have only covered its role in apoptosis and oocyte 
maturation (Inohara et al., 1998; Guillemin et al., 2009). In the current study,  mRNA 
and protein levels of Diva were demonstrated to decrease with neuronal 
differentiation (Fig 3.2-Fig 3.3) in both PC-12 and NSC-34 cell lines. However, this 
result alone could not allow us to conclude if the altered Diva expression was a cause 
or consequence of differentiation, hence the protein was overexpressed to further 
study the issue (Fig 3.7). Herein, this study reports that the overexpression of Diva 
did not alter the expression of NDPK B. This is contrary to the account by Kang et al 
(2007) which reported that overexpression of Diva resulted in attenuation of NDPK B 
expression. The study used human 293T cells, which actually did not contain any 
endogenous Diva, whereas the PC-12 cells used in the current study has endogenous 
expression of Diva. Therefore it is possible that the effect of Diva on NDPK B might 
differ between cell types, since even in this study, the overexpression of Diva in 
MSCs actually increased NDPK B expression (Fig 3.26C).  
In differentiated PC-12 cells, the overexpression of Diva resulted in intense 
yellow staining in the cytoplasm, indicating the colocalisation of the 2 proteins, and 
significantly decreased the number of cells with NDPK B in their nucleus (Fig 3.8B 
& C). This suggests that overexpression of Diva was able to sequester NDPK B in the 
cytoplasm and prevented its translocation into the cytoplasm after receiving the signal 
for differentiation. Thus it is postulated that the physiological function of endogenous 
Diva in differentiation might be to block the translocation of NDPK B into the 






4.2 NDPK B expression was upregulated and the protein translocated to the 
nucleus after neuronal differentiation 
By means of real-time PCR, immunoblotting and immunoflorescence, the 
current study identified that NDPK B expression is upregulated after neuronal 
differentiation (Fig 3.2-Fig 3.3). Although the data was not shown, the NDPK B 
antibody was tested to ensure that it did not cross react with the NDPK A protein, 
which confirmed that only the NDPK B isoform was being observed. The change in 
NDPK B expression in differentiation is in line with previous studies, which has 
shown that NDPK B is involved in a variety of cellular functions in association with 
embryogenesis, such as migration, differentiation and proliferation (Lombardi et al., 
2000; Amendola et al., 2001; Otero et al., 2000). However, the mechanisms 
underlying the role of NDPK B in neural differentiation still remain vague and 
unclear.  
Although NDPK isoforms are found primarily in the cytoplasm, they have also 
been detected in the nucleus. The translocation of NDPK to aid its function has been 
observed in several studies. During caspase independent cell death, Granzyme A 
cleaves SET, a nucleosome assembly protein which inhibits NDPK A. This releases 
NDPK A to translocate to the nucleus to nick chromosomal DNA (Fan et al., 2003). 
NDPK B associates with Estrogen Receptor β associated protein and localizes to the 
nucleus when stimulated with estrogen (Rayner et al., 2007). Kraeft et al (1996) has 
reported an association of NDPK B with chromatin in interphase nuclei but not all 
interphasic cells exhibit nuclear staining, leading to the possibility that the NDPKs 
may be needed in the nucleus only at a certain cell-cycle phase. In the current study, 
the translocation of NDPK B into the nucleus after differentiation was detected (Fig 






unelucidated. Therefore I hypothesized that NDPK B might be regulating 
differentiation by cell cycle control. After all, NDPK A has been demonstrated to 
inhibit proliferation and cause cell cycle arrest in PC-12 cells, by 
hypophosphorylation of pRb2/p130 (Gervasi et al., 1996; Lombardi et al., 2001). 
NDPK A might cause cell cycle arrest by positively regulating p53 (Jung et al., 2007). 
While NDPK B has also been shown to cause cell cycle arrest, it was examined in the 
context of its role as a tumor suppressor in cancer (Syed et al., 2005). Hence, the 
current investigation about the effect of NDPK B on cell cycle progression in PC-12 
cells is a fresh approach to understanding the role of NDPK B in neuronal 
differentiation. 
 
4.3 NDPK B inhibits cell cycle progression 
In order to clarify if expression of NDPK B could promote differentiation by 
causing cell cycle arrest, the protein was overexpressed (Fig 3.16) and its cell cycle 
effects were examined. The present results with BrdU staining showed that NDPK B 
decreased cellular proliferation, resulting in less S-phase cells, in both 
undifferentiated and differentiated cells (Fig 3.21). The expression of NDPK B alone 
was able to bring the proliferation rate of the control cells down to near NGF-treated 
levels and additional NGF treatment caused a further decrease (Fig 3.21 B). This 
result concurs with the previous reports that NDPK B inhibited cellular proliferation 
(Lee et al., 2007; Lee et al., 2008). The suggested mechanism is that NDPK B 
interacts with protein phosphatase 2A (PP2A) which regulates the extracellular signal 
regulated kinase (ERK) pathway that is a major pathway for mitogen-dependent 
cellular proliferation. However, following PI/FACS, the results suggested that the 






longer period in G1-phase of the cell cycle (Fig 3.22). How NDPK B is linked to the 
cell cycle is still relatively poorly understood, although a recent paper by Bosnar et al 
(2004) has reported that NDPKs were needed at a particular point in cell cycle. There 
was intense nuclear staining of NDPKs in late G1 and G2/M phase, while the nuclei 
were unstained in the S phase cells. The authors suggest that intense staining in late 
G1 phase cells could be due to the cells preparing for DNA replication, and NDPKs 
were required to supply the nucleus with dNTPs needed. However, this suggestion 
does not fit in with the current findings, since there were fewer dividing cells when 
NDPK B was overexpressed. 
The alternative hypothesis for how NDPK B could regulate cell cycle is by 
gene regulation. There has been clear evidence of NDPK B as a transcriptional factor 
with DNA binding and cleavage properties. The protein has been shown to regulate 
transcription of PDGF-A and c-myc genes (Postel et al., 1993; Ji et al., 1995). 
Recently, NDPK B has been identified as an activator of several genes required for 
early myeloid differentiation through recognition of c-myc NHE-like elements (Postel 
et al., 2000). Hence it is possible that after receiving differentiating signals, NDPK B 
could translocate to the nucleus to activate or repress genes needed for cell cycle 
progression and/or differentiation. Thus, after NDPK B was overexpressed, the 
transcriptional expression of genes controlling the cell cycle was investigated. The 
data in this study showed that NDPK B retarded cell cycle entry through altered p27, 
cyclin D1, Rb and E2F-1 gene regulation (Fig 3.23). The protein levels of these 
proteins and amount of phosphorylated Rb were also changed due to the ectopic 
expression of NDPK B (Fig 3.24).  
The overexpression of NDPK B resulted in a delay in expression of cyclin D1 






has also been shown to inhibit cell cycle by downregulating cyclin D1 (Choudhuri et 
al., 2010). However, while NDPK A inhibits CDKI expression, the current results 
demonstrated that CDKI levels were elevated, thereby showing that the mechanism 
for cell cycle arrest by NDPK B differs from NDPK A. The blockade in cell cycle 
progression by preventing the accumulation of cyclin D has been documented 
previously (Shivakumar et al., 2002). PTEN, a tumour suppressor that arrests cells in 
G1-phase, was shown to reduce cyclin D1 and D3 levels and prevent its localization 
to the nucleus during the G1- to S-phase cell cycle transition, resulting in a marked 
decrease in Rb protein phosphorylation (Zhu et al., 2001; Radu et al., 2003). 
Terminally differentiated neural cells are arrested in G0, and it would be 
logical for key positive regulators of the cell cycle to be downregulated. Interestingly, 
cyclin D has been found to increase in PC-12 differentiation. Yan and Ziff (1995) 
showed that cyclin D1 was highly increased after induction of differentiation by NGF, 
but the associated kinase activity decreased. Xiong et al. (1997) also showed that 
overexpression or antisense inhibition of cyclin D1 had little effect on kinetics or 
extent of differentiation. Both authors suggested that cyclin D1 may be needed for 
growth arrest prior to differentiation. Kranenburg et al (1995) reported that in 
neuroblastoma cells, induction of differentiation resulted in cyclin D1 downregulation 
but increased cyclin D3 levels. Nonetheless, the differing levels of cyclin D had little 
residual effect on cyclin/CDK activities which declined progressively throughout 
differentiation. They concluded that inhibition of cdk activity by p27, leading to loss 
of pRb phosphorylation, is the major determinant for neuronal differentiation.  
Hence, p27 levels were also studied. The results showed that p27 protein was 
elevated by NDPK B expression (Fig 3.23-3.24). p27 is important in the G0-S 






inhibits Cdk-2 activity and accordingly increase the G0-S interval. The increased p27 
protein expression would fit into the framework of how NDPK B promotes neuronal 
differentiation. The accumulation of CDKIs has been observed in many differentiated 
cell types because differentiation is linked with reduced CDK activity in G1 
(Matsuoka et al., 1994; Parker et al., 1995). A direct effect of p27 on neuronal 
differentiation was demonstrated by Baldassarre et al (2000) which showed that 
transfection of anti-sense p27 molecules resulted in failure to block cell growth and 
induce differentiation. Other than neuronal differentiation, p27 is also associated with 
oligodendrocytic and astrocytic differentiation (Casaccia-Bonnefil et al., 1997; Tikoo 
et al., 1997). Thus it seems that regardless of the lineage, strong p27 expression may 
be required to block CDK activity and for terminal mitosis and cell cycle exit.  
Although the current data also showed an upregulation of p15 expression after 
NDPK overexpression, it is unclear if the prolonged cell cycle arrest was due to the 
action of p15 per se. p15 has been described as a potent effector of TGF-β cell cycle 
arrest (Hannon and Beach, 1994). However, there is also evidence that INK4 proteins 
depend on Cip/Kip proteins to induce G1-phase arrest. Reynisdottir and Massague 
(1997) showed that induced p15INK4b encouraged redistribution of p27 from 
cyclinD-CDK complexes to cyclinE-CDK2 complexes, without increase in p27 
synthesis. 
Since NDPK B caused the downregulation of cyclin D1 and D3 expression , 
with upregulation of both p27 and p15, evidence points towards NDPK B promoting 
differentiation by accumulation of CDKIs, with consequential decrease in cyclin/CDK 
activity. As a final check of this mechanism, I also studied the expression of pRB and 
E2F-1, which lies downstream of cyclin/CDK activity. E2F-1, E2F-2 and E2F-3 are 






lowered by high CDKI expressions would result in the loss of free E2F complexes. In 
turn, there would be the transcriptional repression of E2F-responsive promoters, 
accompanied by exit from cell cycle and terminal differentiation (Sidle et al., 1996). 
This hypothesis is supported by the diminished expression E2F-1 to E2F-3 as the 
neurons differentiated (Dagnino et al., 1997). In line with my hypothesis, cells with 
enforced expression of NDPK B had attenuated expression of pRb (Fig 3.24E) and 
had delayed accumulation of E2F-1 (Fig 3.24F). The decreased E2F-1 expression 
would lead to a slower progression into S-phase thereby supporting the inhibition in 
cellular proliferation by NDPK B. Hence, in this study I successfully established the 
link between NDPK B and cell cycle withdrawal which is mandatory during PC-12 
neuronal differentiation. 
A caveat is that it is unclear if all these proteins could have a direct effect on 
cell cycle, or only a subset of these proteins would be responsible for the cell cycle 
delay. Enforced Bcl-2 expression was also shown to postpone cell cycle entry by 
elevating p27, pRb, p130 and E2F-1, but retardation in cell cycle was later found to be 
independent of pRb (Vairo et al., 2000). Moreover, the mechanism(s) how NDPK B 
could regulate the expression of these proteins remain to be elucidated. There are 
several suggested mechanisms. Firstly, NDPK B is able to phosphorylate Ser residues 
(Dorion et al., 2006), and phosphorylation at Ser10, the major site of phosphorylation 
of p27Kip1, has been shown to contribute to its stability (Ishida et al., 2000). So it 
could be causing the sustained expression of p27, which could then decrease pRb, 
leading to less E2F-1 available to transcribe more cyclin D genes. Secondly, NDPK B 
could directly alter the transcription of genes, since it is able to bind to DNA. 
In addition, although the current data in the study only supports the cell cycle 






the cell cycle proteins might be affecting neuronal differentiation in an unknown 
mechanism apart from its role in cell cycle. For example, pRb has been demonstrated 
to have an important role in neurogenesis (Clarke et al., 1992; Jacks et al., 1992), and 
becomes essential immediately after commitment to a neuronal fate and that apoptosis 
occurs in its absence (Slack et al., 1998). 
 
4.4 Diva is likely to control the cell cycle via NDPK B regulation 
The overexpression of Diva in NGF-treated cells resulted in diminished 
translocation of NDPK B into the nucleus where it controls the regulation of cell cycle 
machinery. Thus we observed cell cycle effects that were opposite of NDPK B 
overexpression. There was increased cellular proliferation (Fig 3.12) and faster 
release from cell cycle arrest (Fig 3.13A & B). This was accompanied by a faster 
accumulation of cyclin D1, a less persistent expression of p27 and p15, as well 
increase in pRb and E2F-1 mRNA and protein levels (Fig 3.13-3.14). Thus it is 
probable that during neuronal differentiation, Diva controls the cell cycle via NDPK 
B regulation, at least to a certain extent. As the overexpression of Diva in the 
undifferentiated group, where NDPK B is not found significantly in the nucleus, also 
caused an increase of cell proliferation, it indicates that there is another unknown 
mechanism that Diva uses to affect cell cycle regulation. Bcl-2 family has been shown 
to regulate cell cycle by targeting the ER and mitochondria (Jamuyan et al., 2003), 
and Diva has also been demonstrated to be localize in the ER and mitochondria (Lee 
et al., 2001), so that is a possible mechanism that Diva might use to effect NDPK B-
independent cell cycle effects. 
Nonetheless, this study has clarified that the downregulation of Diva during PC-12 






that it would be able to inhibit cell cycle progression and allow neuronal 
differentiation. 
 
4.5 Diva is an anti-apoptotic protein 
From the cell cycle results, the percentage of apoptotic cells found in the sub-G1 
phase after overexpression of Diva was also analyzed. The overexpression of Diva 
attenuated apoptosis due to serum starvation (Fig 3.13C). This supports the other 
reports that Diva is an anti-apoptotic member of the Bcl-2 family (Song et al., 1999; 
Ke et al., 2000; Zhai et al., 2008). During PC-12 cell differentiation, Diva expression 
is down-regulated while NDPK B expression increases (Fig 3.2 and 3.3). However, 
no significant cell death was observed. When NDPK B was overexpressed, there was 
a decrease of Diva mRNA and protein levels, and upregulation of β-tubulin levels 
(Fig 3.15C-E), which mirrors the expressions of these proteins during differentiation. 
Similarly, when NDPK B was overexpressed in PC-12 cells, there was no significant 
increase in the percentage of apoptotic cells found in the sub-G1 phase (results 
section 3.15). A likely explanation for this would be that there may be overlapping 
functions between the members of the Bcl family, as revealed by many knockout mice 
studies (Youle and Strasser, 2008). Therefore the downregulation of Diva during 
differentiation could have been compensated by another anti-apoptotic Bcl protein, 
resulting in no substantial cell death.  
However, as artificial knock-down of Diva results in cell death (Song et al., 1999; 
Ke et al., 2000), it might be difficult to investigate the effect of Diva deficiency and 








4.6 Endogenous Diva, NDPK B and β-tubulin interact with one another 
An earlier study by Kang et al (2007) had reported that ectopically expressed Diva 
interacts with NDPK B. Therefore I investigated whether endogenous Diva also 
interacts with NDPK B in PC-12 cells and thereby clarified the function of this 
association. Using immunoprecipitation, the current results showed that endogenous 
Diva did interact with NDPK B in the normal cells (Fig 3.4), and the interaction was 
localized in the cytoplasm as both proteins were cytoplasmic (Fig 3.5A). In addition, 
the current results also showed that Diva binds to β-tubulin as well (Fig 3.4). Since 
the Duolink kit allows us to only study proteins that are bound directly to each other, I 
was able to confirm that the Diva/β-tubulin complex was present in the cells (Fig 
3.5B). NDPK B/ β-tubulin complexes were also detected by the Duolink kit (Fig 
3.5C). Previously, Lombardi et al. (1995) reported that NDPK A could be co-
immunoprecipitated with β-tubulin, showing a physical interaction between both 
proteins, and the number of complexes increased during the cellular differentiation 
process. However there is some contention as to whether the interaction is direct or 
indirect (Gallagher et al., 2003; Pinot et al., 1999). The discrepancy regarding the 
direct or indirect interaction of the proteins might be due to the highly dynamic nature 
of microtubules, which are constantly undergoing dynamic assembly and disassembly 
within a cell. Hence, the physiological state of the cell might be a reason why some 
authors were unable to co-immunoprecipitate the two proteins together. Nonetheless, 
the current results support the view that there is direct interaction between NDPK B 
and β-tubulin, since both immunoprecipitation (Fig 3.4) and Duolink proximity 







4.7 NDPK B and β-tubulin interaction promotes microtubule polymerization 
and leads to outgrowth of neurites 
In the current results, I also showed that NGF treatment led to an upregulation in 
β-tubulin levels (Fig 3.2B) and that the interaction between NDPK B and β-tubulin 
(Fig 3.4B and 3.5C) increased after differentiation. Tubulin consists predominantly 
of two 55 kDa subunits (α and β), which combine stoichiometrically to form 
heterodimers (Jordan and Wilson, 1998). They form the principal structural 
component of microtubules and are supplemented with accessory microtubule-
associated proteins (MAPs), chaperonins, G proteins and protein kinases (Tian et al., 
1996). Tubulin phosphorylation allows the microtubules to attach more efficiently to 
the MAPs and increase microtubule stability, as exemplified in neurite outgrowth 
(Haendel et al., 1995). Microtubules, in addition to intermediate filaments 
(neurofilaments), and microfilaments (actin filaments), form the 3 main cytoskeleton 
proteins that are the subcellular structures responsible for genesis, maintenance, 
stability, and functionality of neurites (Pannese, 1994). In turn, the distinct 
morphology of neurons rests in their ability to generate neurites, and it is therefore 
one of the hallmarks of neuronal differentiation.  
Lombardi et al (1995) suggest that NDPK might transphosphorylate β-tubulin and 
stabilize it, and that the association between the 2 proteins might be important in 
regulating the cytoskeleton network during differentiation. Hence to investigate if 
formation of NDPK/β-tubulin complex is for the polymerization of microtubules, I 
used taxol, a microtubule polymerizing drug, to see if that would affect the amount of 
NDPK/β-tubulin complexes. Indeed, I observed that after taxol treatment, the level of 
NDPK B/β-tubulin complexes was augmented; indicating that their association was 






in with the evidence in reports which have shown that the binding of NDPKs 
facilitated microtubule assembly (Nickerson and Wells, 1978; Lombardi et al., 2002; 
Ikeda, 2010). 
In view of the current evidence, I postulated that the physiological role that NDPK 
B plays in the cytoplasm during neuronal differentiation might be to promote neurite 
outgrowth by facilitating microtubule polymerization. Hence, I overexpressed NDPK 
B protein in the PC-12 cells and report that these cells had a more branched 
morphology, with greater outgrowth of neurites when exposed to NGF (results 
section 3.12). It is rational that NDPK B would bind to microtubules to supply it with 
the high amount of nucleotides needed for microtubule polymerization that is needed 
for neurite outgrowth. In a report closest to our findings, Gervasi et al (1996) 
addressed whether NDPK A was capable of influencing the neuronal differentiation 
process of NGF-stimulated PC-12 cells. By altering the intracellular levels of the 
protein using sense and anti-sense transfections, they found that overexpression of 
NDPK A stimulated neurite outgrowth, with longer branching neurites, while the anti-
sense transfectants had fewer cytoplasmic extensions or branching neurites. Their 
study did not show if NDPK B had the same effect. Given that both NDPK isoforms 
have been shown to have non-overlapping functions, it is therefore important to 
investigate if NDPK B is also involved in NGF-stimulated outgrowth of PC12 
neurites. Therefore, the current study has shown that NDPK B promoted the 









4.8 Downregulation of Diva during differentiation facilitates NDPK B/β-
tubulin complex formation and neurite outgrowth 
More interestingly, the study demonstrated that the amounts of Diva/β-tubulin and 
Diva/NDPK B complexes were attenuated after taxol treatment (Fig 3.6A & C), 
suggesting that decreasing the critical concentration for tubulin assembly would cause 
a shift in preference for the NDPK B and β-tubulin to complex with each other rather 
than with Diva. Thus, there seems to be a certain balance between these 3 proteins 
that would alter according to the physiological condition of the cell. 
During differentiation, as the expression of Diva is downregulated, a decrease in 
the amount of Diva/NDPK B and Diva/β-tubulin complexes was observed (Fig 3.4 & 
3.5). This was accompanied by elevated amounts of the NDPK B/β-tubulin complex, 
which could be a result of the increased expression of both proteins, as they are 
needed for microtubule polymerization during differentiation. Hence I postulated that 
if Diva was overexpressed and then the Diva-overexpressing cells were subjected to 
NGF treatment, I would be able to determine if the downregulation of Diva during 
differentiation was necessary, so as to allow the association between NDPK B and β-
tubulin, thereby aiding microtubule polymerization. The current results showed that 
the overexpression of Diva caused an increased number of complexes of the protein 
with β-tubulin (Fig 3.9) and NDPK B (Fig 3.10), and consequentially inhibited the 
formation of NDPK B/β-tubulin complexes (Fig 3.11). To further confirm that the 
physiological function of Diva was to prevent formation of the NDPK B/β-tubulin 
complex which would affect neurite outgrowth, we counted the percentages of 
differentiated cells and their average neurite length in the (Fig 3.8 D & E), and Diva-






Therefore, this supports my hypothesis that physiologically, the role of Diva in 
differentiation was to inhibit the association between NDPK B and β-tubulin, and its 
expression would be downregulated during differentiation to allow more NDPK B/β-
tubulin complexes to form. This is an interesting contribution to understanding how 
Diva controls the cytoskeleton. Diva has been reported to regulate microtubule 
dynamics by binding TCTP and via calcium signaling (Guillemin et al., 2009; 
Popgeorgiev et al., 2011).  
In addition, the impact of Bcl-2 in neurite outgrowth in PC-12 cells is ambiguous. 
A study by Batistatou et al (1993) reported that Bcl-2 affects only survival, but not 
neurite outgrowth. In contrast, Sato et al (1994) showed that Bcl-2-transfected PC12 
cells had outgrowth of long processes when serum deprived, but had no neurite 
formation when cultured with serum, and concluded that differentiation was a result 
of the prevention of cell death.  
In summary, this study has demonstrated that Diva is anti-apoptotic and regulates 
microtubule dynamics. Thus, Diva might affect differentiation bifunctionally, by 
aiding cell survival and affecting neurite outgrowth. This concurs with the observation 
that Diva controls differentiation in the development of the zebrafish by apoptosis-
dependent and –independent mechanisms (Arnaud et al., 2006).  
 
4.9 Diva and NDPK B encourage the differentiation of MSCs into 
oligodendrocyte-like cells 
Recently, NME2/NDPK B has been linked with a role in embryonic stem cell 
(ESC) self-renewal. Gene expression analysis has shown that NME2/NDPK B is 
highly expressed in ESCs but has decreased expression after differentiation (Yang et 






localization of NME2/NDPK B and increased the efficiency of the directed 
differentiation of ESCs to endodermal lineage. On the other hand, NME1/NDPK A 
has also been shown to bind to MUC1 and regulate the self-renewal of ESCs (Hikita 
et al., 2008). Other Bcl-2 family proteins such as Bcl-2 and Bcl-xL have been shown 
to have a part in differentiation by determining neural lineage of stem cells (Shim et 
al., 2004; Liang et al., 2003; Courtois et al., 2010). Antidepressant treatment was 
demonstrated to increase NSCs survival, promote neurite development, and facilitate 
NSCs differentiating into functional serotoninergic neurons via the modulation of Bcl-
2 expression through the ERK pathway (Chiou et al., 2006; Chen et al., 2007). A 
pluripotent stem cell line that overexpressed Bcl-2 shifted the distribution of 
differentiated cells from neurons to oligodendrocytes (Esdar et al., 2001). Hence, the 
next step of the current study was to examine the effect of NDPK B and Diva in 
MSCs to investigate the plausible roles of these proteins in MSC differentiation. 
Thus, rat MSCs were isolated and characterized to confirm their identity and 
multipotentiality (Fig 3.25). Next, the interplay of Diva and NDPK B was 
investigated by overexpressing these proteins individually in the primary MSCs (Fig 
3.26). The control cells showed MSCs to express Diva and NDPK B endogenously 
(Fig 3.26A), and they were both localized in the cytoplasm. The overexpression of 
NDPK caused ectopic expression of NDPK B in the cytoplasm and nucleus (Fig 3.26 
B & C). Unexpectedly, the overexpression of NDPK B did not appear to affect the 
expression of Diva (Fig 3.26B), although it still increased the percentage of 
differentiated cells (Fig 3.26D). The positive effect of NDPK B expression in the 
nucleus on MSC differentiation is contrary to the report by Zhu et al., (2009) that 
postulates that NDPK B inhibits differentiation of ESC because it transcriptionally 






contention regarding the ability of NDPK B to even activate c-myc transcription 
(Michelotti et al., 1997). In addition, even if it is in the nucleus, NM23-H2/NDPK B 
will still be inhibited from activating c-myc transcription if the DNA secondary 
structures formed within the NHE III1 region of the c-myc gene promoter are 
stabilized (Dexheimer et al., 2009). This study did not investigate the activation of c-
myc by NDPK B, so I am unable to discuss if the effect of NDPK B on MSC 
differentiation could involve c-myc regulation and can only suggest that NDPK B 
may contribute to MSC differentiation via cell cycle inhibition (discussion point 10). 
The differing results in the experiments could be due to NDPK B playing different 
physiological roles in the different cell types, since it has multi-faceted functions. 
In addition, Diva overexpression resulted in elevated expression of NDPK B (Fig 
3.26C). An even more interesting observation was that in the groups overexpressing 
either protein, I found cells with an altered morphology resembling neural cells, with 
rounded bodies with neurite outgrowth. In these neural-looking cells, there was strong 
expression of both Diva and NDPK B and both proteins colocalized in the cytoplasm. 
To determine the neural identity of these cells, the transfected cells were stained with 
various neural cell markers, and the cells were shown to stain positively with CNPase 
(Fig 3.27).  
Hence, the data suggests that the upregulation of both Diva and NDPK B in MSCs 
caused them to differentiate along an oligodendrocytic lineage. The current 
observation regarding the expression of Diva is supported by evidence that Diva is 
present in oligodendrocytes and its gene expression increases during the course of 
oligodendroglial differentiation (Itoh et al., 2003). This is a rather interesting 
observation. In both PC-12 neuronal differentiation and MSC differentiation into 






data suggests that a downregulation of Diva expression would lead to a neuronal fate, 
whereas an upregulation of Diva would promote oligodendrogenesis. Nonetheless, 
this is only a postulation and needs to be supported by data showing that directed 
differentiation of MSCs into neurons and oligodendrocytes also have differing 
expressions of Diva. 
This insight into the involvement of Diva and NDPK B in oligodendrogenesis 
would be useful in improving strategies to control MSCs-derived oligodendrocyte 
differentiation in vitro. In turn, this would be valuable in the application of MSCs-
derived oligodendrocytes for graft-based remyelination therapy for diseases such as 
multiple sclerosis (MS). MS is a neurodegenerative disease of the CNS that is 
characterized by inflammation, demyelination with associated oligodendrocytes and 
axonal loss. For patients who fail to respond to conventional immunosuppressive and 
immunomodulating drugs, stem cell therapy poses as a rational approach for 
neurological regeneration (Cristofanilli et al., 2011). Recently, a consensus report on 
the use of MSCs for the treatment of MS, along with protocols for the culture of the 
cells and the treatment of patients was generated by the International Multiple 
Sclerosis Clinical Trial Study Group (Freedman et al., 2010). MSCs are promising 
vehicles for MS treatment because transplantation with autologous or allogeneic 
MSCs has been well tolerated by patients, and their secretion of immunomodulatory 
and neurotrophic growth factors limit CNS inflammation, stimulate neurogenesis, 









4.10 Diva is likely to have NDPK B-independent mechanisms in cell 
cycle control in MSCs 
In the transfected MSCs, NDPK B overexpressing cells had lesser S-phase cells, 
retarded cell cycle entry and increased susceptibility to apoptosis initially, although 
sub-G1 levels were indistinguishable from normal cells by 24 hrs (Fig 3.28-3.29). 
These cells also had elevated p27 levels and decreased cyclin D1 levels (Fig 3.30). 
Hence, NDPK B is likely to affect MSC differentiation by regulating cell cycle arrest.  
The current results present that the overexpression of Diva resulted in more S-
phase cells than the control (Fig 3.28) and faster entry into the cell cycle after serum 
starvation (Fig 3.29). This appears to be contrary to the current discussion since Diva 
is highly expressed in cells with a differentiated morphology and should therefore be 
arresting the cells rather than promoting their cell cycle progression.  There are 
several plausible explanations. Firstly, as seen in Fig 3.26E, the percentage of 
differentiated cells after Diva overexpression was very low, at only 3.4%. Hence, the 
PI/FACs results represented the majority of the undifferentiated cells. It does not 
denote the role of Diva in the regulation of cell cycle pertaining to MSC 
differentiation to an oligodendrocytic lineage. Secondly, we cannot rule out the 
possibility that the MSCs were carrying out their terminal mitosis before 
differentiation into oligodendrocytes. This study also reported a faster decrease in p27 
levels in parallel to an increase in cyclin D1 levels (Fig 3.30). Previous studies have 
shown that cells overexpressing BCL-2 or BCL-xL cells are able to stabilize p27 due 
to Bax and Bak (Janumyan et al., 2008). Diva has been shown to bind and regulate 
Bax and Bak (Ke et al. 2001), so although results from this study do not allow us to 
conclude if Diva affects the translocation of NDPK B in the case of MSCs, it could 






In the MSCs, Diva was also able to attenuate apoptosis due to serum starvation 
(Fig 3.29). Overexpression of Bcl-2 has been shown to overcome the growth 
restriction of progenitor cells (Huang et al., 1999). A recent report by Oliver et al 
(2011) has presented an interesting result. They demonstrated that in hMSCs, the 
expression of Bcl-2 is apparent only in differentiated cells and can be either pro- or 
anti-apoptotic. Bcl-xL expression, on the other hand, is constant and exhibits an anti-
apoptotic activity under all conditions. In vitro oligodendrocyte differentiation is 
usually initiated by removal of trophic factors, but it triggers gradual death of 
differentiated oligodendrocytes by apoptosis due to a lack of interaction with other 
CNS components (Barres et al., 1992). Thus, the forced expression of Diva in vitro 
would be useful in promoting the survival of the MSCs and promoting their 
differentiation into an oligodendrocytic lineage. 
 
4.11 Diva’s association with NDPK B holds the key to fate 
determination? 
There were increased associations between Diva, NDPK B and β-tubulin only in 
MSCs with differentiated morphologies (Fig 3.31). While NDPK B/β-tubulin 
interaction is most likely for microtubule polymerization, the current data suggests 
that the role of Diva in oligodendrogenesis is different from neuronal differentiation. 
For PC-12 cells, expression of Diva inhibited neurite outgrowth, and yet transfection 
of Diva in MSCs resulted in a differentiated phenotype. A suggested explanation for 
these conflicting reports could be that the expression of Diva has an impact on cell 
fate determination, since observations reported in PC-12 cells was for neuronal 
differentiation and the differentiated cell type observed in the MSCs is 






novel, the interaction of other Bcl-2 proteins, such as Bax and Bak, with tubulin has 
been reported (Knipling and Wolff, 2006). Previous studies have shown that the 
protective effect of Bcl-2 on the neuronal cytoskeleton is probably linked to the 
stabilization of tubulin via post-translational modification (Nuydens et al., 2000; 
Porcelli et al., 2008). Hence in the case of oligodendrocytic differentiation, it is 
plausible that Diva is stabilizing the microtubules. Alternatively, because 
microtubules bind many signaling elements such as phosphatases, lipid kinases and 
GTPases (Janmey, 1998), association with the cytoskeleton might be to mediate the 
recruitment of Diva to multimeric signaling complexes whose functions have yet to be 
elucidated. The function for the interaction of Diva with NDPK B in the cytoplasm is 
also still unknown, but perhaps this association is the determining factor for 
differentiation into the oligodendrocytic lineage, since formation of Diva/NDPK B 
complexes was specifically intensified in oligodendrogenesis but was downregulated 






















Figure 4. Postulated roles of Diva and NDPK B in cellular differentiation 
The undifferentiated cell has basal expressions of NDPK B, Diva and β-tubulin in the 
cytoplasm. Upon receiving signals for neuronal differentiation, Diva is downregulated 
and NDPK B is upregulated. The combined effect is to increase the amount of NDPK 
B/β-tubulin complexes, thereby leading to neurite outgrowth. Also, NDPK B 
translocates to the nucleus where it alters the expression of cell cycle machinery, 
resulting in cell cycle arrest and decreased proliferation. In oligodendrogenesis, there 
is an upregulation of both Diva and NDPK B proteins. This increases the amount of 
NDPK B/β-tubulin complexes, which is likely to facilitate process outgrowth. 
Diva/NDPK B complexes also increase in number and may be the determining signal 
for oligodendrogenesis over neurogenesis. Cell cycle and proliferation is also 
inhibited by NDPK B expression in the nucleus and subsequent changes in p27 and 
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4.12 Cell cycle inhibition without disruption to differentiation is a 
strategy for treatment of the CNS 
 In the last decade, there has been in vivo evidence of DNA replication in 
disease states such as AD (Yang et al., 2001), epilepsy (Nagy and Esiri, 1998), PD 
(Jordan-Scuitto et al., 2003) and ALS (Ranganathan and Bowser, 2003). Cell cycle re-
entry was also further confirmed in animal models of AD (Herrup et al., 2004), ALS 
(Nguyen et al., 2003) and TBI (Di Giovanni et al., 2005). These studies challenged 
the concept that post-mitotic neurons were terminally differentiated and confined in 
the G0 quiescent phase, and demonstrate aberrant cell cycle re-entry as a 
characteristic of CNS disorders with dying neurons. The hypothesis is that, upon 
receiving stimulation from pro-mitogenic molecules such as nitric oxide, Aβ and 
reactive oxygen species (ROS) that were released from injured neurons, there is 
elevation of cell cycle proteins and the neurons exit their quiescent state and re-enter 
the cell cycle. These mature neurons that enter the cell cycle were neither able to 
advance to a new G0 state nor revert to its earlier G0 resting state. Thus death became 
an unavoidable but necessary consequence for them to complete the cell cycle. For 
example, Aβ challenged neurons proceeded into the S phase before dying (Copani et 
al., 1999). This G1/S transition in cell cycle reactivated neurons was affirmed by 
fluorescent in situ hybridization in AD patient samples (Yang et al., 2003). The failure 
to complete the cell cycle may be explained by a possible loss or inhibition of cell 
cycle progression factors in the mature neurons, and results in the trigger of cell death 
mechanisms to rid the tissue of these cells. Since cell cycle inhibition can prevent a 
neuron from re-entering the cell cycle, which results in the neuron death (or loss) that 
is a general consequence of CNS diseases, it will then be a candidate strategy for the 






proteins but also the mitogenic molecules and signaling pathways interacting with 
them has been described as a therapeutic target for treatment of CNS diseases because 
they share the common outcome of cell cycle inhibition (Liu et al.; 2010). 
An even more intriguing point is that aberrant cell cycle re-entry is also seen 
in tumour cells (Ishikawa et al., 2009), which also originates from G0 resting cells but 
enjoy uncontrolled proliferation. Park et al (1996 and 1997) demonstrated that CDK 
inhibition conferred protection to NGF-differentiated PC-12 cells, while promoting 
the death of naïve PC-12 cells. It is therefore an attractive idea that cell cycle 
inhibition can have a dual effect of protecting neurons and killing tumor cells at the 
same time. Indeed, CDKIs such as Falvopiridol and Roscovitine have been used as 
cancer therapeutics in human clinical trials (Wyatt et al., 2008). In addition, there is 
preclinical data that these agents also improve behavioural outcomes and increase 
neuronal survival in AD, PD (Kruman and Schwartz, 2006) and TBI (Di Giovanni et 
al., 2005). However, there are side effects due to non-specificity, such as cognitive 
dysfunction when cell cycle inhibitors are used in cancer therapeutics (Konat et al., 
2008), and efforts are underway to develop more selective compounds targeting 
specific CDKs (Bain et al., 2007 and Hirai et al., 2005). 
Therefore, the results of this study have presented a novel and intriguing 
possibility in stem cell therapy. The expression of Diva is suggested to have a role in 
cell fate determination during differentiation. Hence, modification to Diva levels 
could be a promising strategy to encouraging the enrichment of a particular cell type 
from stem cells. Although Diva has an anti-apoptotic function as well, overexpression 
of the protein is not necessarily beneficial since it prevents neurogenesis. Thus Diva 






progenitor cellular proliferation, while encouraging differentiation. This would be 
useful in disease models such as MS.  
Although stem cells have been poised as a solution to a myriad of CNS diseases, 
currently its use is limited by the propensity for teratoma formation after 
transplantation (Aleckovic and Simón, 2008). Hence, the overexpression of NDPK B, 
which works coordinately with Diva in oligodendrogenesis, could possibly aid in 
preventing teratomas formation by targeting the cell cycle. Most importantly, it is able 
to achieve this without negatively affecting neurogenesis. This is an important point 
since this is the pitfall of current cell cycle inhibitor strategies (Dietrich et al., 2008). 
In cases of brain carcinoma treatments, NDPK B would aid in stopping proliferation 
and metastasis of tumour cells, while having a positive effect on neuroprogenitor cells 













 CONCLUSIONS AND FUTURE STUDIES 
  






This study aimed to elucidate the role of Diva in differentiation and has shown that 
Diva negatively regulates differentiation. Its downregulation during differentiation is 
necessary for the increased formation of NDPK/β-tubulin complexes that mediates 
microtubule polymerization for neurite outgrowth. In addition, decreased expression of 
Diva was required for translocation of NDPK B into the nucleus, to  alter expression of 
cell cycle machinery and thus decrease cellular proliferation. In detail, the present study 
comes to these conclusions: 
1. Diva expression is downregulated whereas NDPK B expression is upregulated 
after PC-12 neuronal differentiation. 
2. The interaction between NDPK B and β-tubulin facilitates microtubule 
polymerization that is important for neurite outgrowth. Overexpression of Diva 
did not affect NDPK B expression levels, but decreased the number of NDPKB/β-
tubulin complexes, thereby leading to decreased neurite outgrowth. In contrast, 
the overexpression of NDPK B encouraged the growth of longer processes. 
3. Overexpression of NDPK B resulted in downregulated Diva levels and strong 
expression of NDPK B in the cytoplasm and nucleus, which are characteristics 
observed during PC-12 neuronal differentiation. NDPK B inhibited cellular 
proliferation and cell cycle progression by having elevated p27 levels as well as 
downregulated cyclin D1 and D3 expressions. The amounts of pRb and E2F-1 
were also attenuated. Overexpression of Diva inhibited nuclear translocation of 
NDPK B, hence proliferation rate was increased and there was faster cell cycle 





entry. Consequentially, opposite effects on the cell cycle machinery were 
observed. 
4. Hence, we concluded that the downregulation of Diva expression during PC-12 
neuronal differentiation was necessary to allow the translocation of NDPK B into 
the nucleus to inhibit cell cycling. Decreased expression of Diva in the cytoplasm 
promoted association of NDPK B and β-tubulin that supported neurite outgrowth. 
Both cell cycle arrest and neuritogenesis are necessary hallmarks of neuronal 
differentiation. 
5. Overexpression of Diva and NDPK B respectively in primary MSCs resulted in a 
greater percentage of neural-like cells, which were later identified to be 
oligodendrocyte-like cells.  These cells had strong expressions of both proteins. 
6. NDPK B mediated cell cycle arrest in MSCs, with increased p27 and attenuated 
cyclin D1 levels. There were also more NDPK B/β-tubulin complexes found in 
the oligodendrocyte-like cells, thus the role of NDPK B in neurogenesis and 
oligodendrogenesis is similar. 
7. However, the role of Diva in oligodendrogenesis remains to be elucidated. 
Oligodendrocyte-like cells had increased Diva/β-tubulin and Diva/NDPK B 
complexes but the functions for these complexes are still unclear. 
 
5.2 Future studies: 
In order to examine the function of Diva by physiological expression 
1. The directed differentiation of MSCs into neurons and oligodendrocytes, before 
analysis of the expression of endogenous Diva and NDPK B should also be 





conducted. This would affirm the results that differential expression of Diva is 
integral to cell fate determination. 
2. In vivo staining of normal embryonic mice and Diva and NDPK B knockout mice 
at different stages to see if neuronal development is altered 
     Further molecular analysis 
3. NDPK B knockdown experiments to determine if upregulation and translocation 
of NDPK B is necessary for cell differentiation. 
4. In this study, I have shown that NDPK B promotes differentiation by facilitating 
cell cycle exit. I have determined that this is achieved by altering the expression 
of cell cycle machinery, but I have not elucidated the mechanism by which it 
regulates these cell cycle components. Therefore it awaits future studies to 
determine if the kinase or transcriptional ability of NDPK B, or both, is necessary 
for cell cycle regulation. 
5. It would be interesting to investigate if NDPK B or Diva is involved in 
differentiation by having a role independent of cell cycle (eg elaboration of gene 
expression program defining the differentiated cell). 
6. The current results only suggest that Diva and NDPK B work synergistically in 
oligodendrocytes and that the increased amount of Diva/NDPK B complexes 
might be involved in cell fate determination. To characterize the role of the 
complex would be an intriguing issue.  
7. The control of cell cycle inhibition and cell lineage choice via regulation of Diva 
and NDPK B is an exciting proposition for application in stem cell therapy for 
CNS diseases. However, the feasibility to prevent neuronal death and promote 





differentiation remains unproven in vivo, and animal models need to be 
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